CHAPTER
Env-A 1400 REGULATED TOXIC AIR
POLLUTANTS
Statutory
Authority: RSA 125-I:6
PART Env-A
1401 PURPOSE AND APPLICABILITY; DEFINITION
Env-A 1401.01 Purpose.
(a) The
purpose of this chapter is to implement RSA 125-I relative to preventing,
controlling, abating, and limiting the emissions of toxic air pollutants into
the ambient air.
(b) The
ambient air limits (AALs) established in this chapter are
intended to promote public health by reducing human exposure to toxic air
pollutants as required by RSA 125-I:1.
Source. #4489, EMERGENCY, eff 9-15-88; EXPIRED: 1-13-89
New. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97; ss by #8278, eff 2-4-05;
ss by #9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A 1401.02 Applicability. This chapter shall apply to the owner or
operator of any new, modified, or existing process or device located at a
stationary source that emits a regulated toxic air pollutant (RTAP) into the
ambient air, unless exempted under Env-A 1402.
Source. #9601, eff 11-25-09; ss by #9865, eff
2-18-11; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A 1401.03 Definitions. For purposes of this part, the following
definitions shall apply:
(a) “Accidental
release” means an unanticipated emission of an RTAP into the ambient air from a
stationary source, process or device, either caused by an unintentional spill
or a malfunction as defined in Env-A 104;
(b) “Biodiesel”
means a diesel fuel substitute that is composed of mono-alkyl esters of long chain
fatty acids, is derived from vegetable oils or animal fats, and meets the
requirements of the American Society for Testing and Materials (ASTM)
specification D6751;
(c) “Biofuel”
means bio-oil, bio synthetic gas, or biodiesel, alone or in any combination;
(d) “Biomass”
means “biomass” as defined in RSA 125-C:2, III-a, reprinted in Appendix B. The term does not include any mixture
containing the wood component of construction and demolition debris or any
material or mixture containing sewage sludge, industrial sludge, medical waste,
hazardous waste, household or municipal waste, animal or human remains, animal
or human waste, or radioactive waste;
(e) “Bio-oil”
means a liquid fuel derived from vegetable oils, animal fats, wood, straw,
forestry byproducts, or agricultural byproducts using noncombustion
thermal, chemical, or biological processes, including, but not limited to,
distillation, gasification, hydrolysis, or pyrolysis, but not including
anaerobic digestion, composting, or incineration;
(f) “Bio
synthetic gas” means a gaseous fuel derived from vegetable oils, animal fats,
wood, straw, forestry byproducts, or agricultural byproducts using noncombustion thermal, chemical, or biological processes,
including, but not limited to, distillation, gasification, hydrolysis, or
pyrolysis, but not including anaerobic digestion, composting, or incineration;
(g) “Compliance
boundary” means “compliance boundary” as defined in RSA 125-I:2 VI, reprinted
in Appendix B, which is subject to the alternate compliance boundaries
described in Env-A 1404.07;
(h) “Inhalable
fraction” means those materials that are hazardous when deposited anywhere in
the respiratory tract and have an aerodynamic diameter of less than or equal to
100 micrometers (µm);
(i) “Inhalable fraction and vapor” means a material that might be present in both the
particulate and vapor phases;
(j) “Particulate
RTAP” means an RTAP that is a solid at ambient temperature;
(k) “Processed
landfill gas” means gaseous fuel that does not contain more than 0.5 ppm of
total siloxanes;
(l) “Pump
station” means a facility that is part of a publicly owned treatment works
(POTW), that consists of pumps and service equipment designed to pump
wastewater from one location to another or from one elevation to another, in
order to allow continuous treatment within the POTW;
(m) “Respirable
fraction” means a material that is hazardous when deposited in the gas-exchange
region of the lungs with an aerodynamic diameter less than 4.0 µm;
(n) “Thoracic
particulate matter” means a material that is hazardous when deposited anywhere
within the lung airways and the gas-exchange region and is less than 25 µm in
size; and
(o) “Uncontrolled
emission” means “uncontrolled emission” as defined in RSA 125-I:2, XVII,
reprinted in Appendix B.
Source. #9601, eff 11-25-09; ss by #10133, eff
6-1-12; amd by #12063, eff 12-30-16; ss by #12443,
eff 1-5-18; ss by #13334, eff 2-3-22
PART Env-A 1402 EXEMPTIONS FROM APPLICABILITY
Env-A 1402.01 Statutory Exemptions for Sources and
Activities. As specified in RSA
125-I:3, III(a) and (b), the following shall be exempt from regulation under
RSA 125-I and these rules:
(a) Normal
agricultural operations;
(b) The
application of pesticides regulated pursuant to RSA 430:28 through RSA 430:48;
(c) Emissions
of RTAPs resulting from mobile sources; and
(d) Emissions
of RTAPs resulting from the combustion of virgin petroleum products at
stationary sources.
Source. #6468-B, eff 3-5-97; ss by #7859, eff
4-11-03; ss by #8095, eff 6-11-04; ss by #8278, eff 2-4-05; ss by #9601, eff
11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A 1402.02 Additional Exemptions for Sources and
Activities. Pursuant to RSA 125-I:3,
III(c), emissions of RTAPs from devices or processes at a
stationary source shall be exempt from the requirements of this chapter if the emissions
of such RTAPs are from, or result from, any of the following sources or
activities:
(a) The
combustion of one or more of the following fuels:
(1) Coal;
(2) Natural gas;
(3) Propane;
(4) Biofuels as defined in Env-A 1401.03(c);
(5) Biomass as defined in Env-A 1401.03(d); or
(6) Processed landfill gas as defined in Env-A 1401.03(k);
(b) A
gasoline dispensing or storage facility or cargo truck as regulated pursuant to
Env-A 1217 or Env-Or 500;
(c) An
exempt activity as classified in Env-A 609;
(d) A
pneumatic transfer system for collecting sander dust which uses a baghouse that
is operated and maintained in accordance with the manufacturer’s specifications;
(e) Non-metallic
mineral processing plants, as defined in Env-A 2800;
(f) Wastewater
evaporators that do not process wastewater containing volatile organic
compounds (VOCs);
(g) Used
oil heaters that meet the following criteria:
(1) The sum of the gross heat input design
ratings for all devices equals 500,000 Btu per hour or less;
(2) The sum of the fuel use rate for all devices
equals 3.6 gallons per hour of fuel use or less;
(3) All devices burn 8,640 gallons per year or
less of specification used oil as defined in Env-Hw 800;
(4) Each exhaust stack has an inside diameter of
8 inches or less;
(5) Each exhaust stack outlet is 20 feet or more
above the ground;
(6) Each exhaust stack is vertical and
unobstructed; and
(7) All devices are operated and maintained in
accordance with manufacturer’s specifications;
(h) Spray
coating operations used for maintenance limited to painting of process
equipment using commercially available paints or coatings, but excluding VOC
degreasing operations;
(i) Crematoriums;
(j) A
publicly owned wastewater treatment facility that:
(1) Is not required to develop a pretreatment
program to control pollutants received by the POTW from non-domestic sources,
in accordance with 40 CFR 403, General Pretreatment Regulations for Existing
and New Sources of Pollution; and
(2) Has a national pollutant discharge elimination
system (NPDES) permit, in accordance with section 402 of the Clean Water Act,
33 U.S.C. 1251 et seq.;
(k) A
pump station which is part of a publicly owned wastewater treatment facility,
in accordance with (j), above;
(l) The use of consumer products in a manner
consistent with how the general public would use the product;
(m) An
automotive refinishing operation that meets the following criteria:
(1) Each spray booth/station exhaust stack is
vertical and unobstructed;
(2) The source is in
compliance with the requirements of 40 CFR Part 63, Subpart HHHHHH; and
(3) The source uses less than 500 gallons per
year of commercially available paints or coatings;
(n) An
air stripper or other equipment associated with soil venting that is used to remediate
a petroleum or gasoline contaminated site, and equipment that is used to
control petroleum or gasoline vapors at either a petroleum or gasoline
contaminated site or at a site associated with a petroleum or gasoline
contaminated site, provided that such equipment is located at or associated
with a state-funded site, a superfund site, or is required under the provisions
of a consent order or consent agreement with the department;
(o) Routine
maintenance activities associated with boilers;
(p) The
use of isopropyl alcohol, nitrous oxide, and ethylene oxide at health care facilities;
(q) An
accidental release as defined in Env-A 1401.03;
(r) Air
strippers, soil venting equipment, or equipment used to control contaminated
vapors operating for test purposes to qualify and quantify air emissions for
remediation projects for a time period approved by the department;
(s) Solvent
cleaning of parts and equipment performed exclusively by hand wiping or hand
cleaning, provided that:
(1) Less than 20 gallons
per year are used; and
(2) The used wipes are kept
in closed containers;
(t) Process
emissions from private, public, or vocational educational institutions,
provided that:
(1) The emissions are
primarily the result of teaching and training exercises; and
(2) The institution is not
engaged in the manufacture of products for commercial sale;
(u) Degreasing
and cleaning units that exclusively use aqueous caustic solutions at ambient
temperatures in non-aeriated baths or tanks;
(v) Rooms,
buildings, and warehouses used exclusively for:
(1) Storing chemicals,
provided such chemicals are stored in closed containers;
(2) Filling chemical
containers or transferring chemicals from one container to another for use
within the facility; and
(3) Sampling chemicals for
quality assurance and quality control purposes;
(w) Powder
coating operations;
(x) Surface
coating at facilities that do not spray apply coatings containing strontium
chromate (CAS #7789-06-02) and have actual VOC emissions of 1,000 pounds or
less in any 12-month period from all coating materials, coating material
components, other materials mixed with coating materials prior to application,
and cleaning solvents; and
(y) Particulate
RTAP emissions that are vented inside the building and, in aggregate, do not
exceed 1,000 pounds in any consecutive 12-month period.
Source. #9601, eff 11-25-09; amd
by #9865, eff 2-18-11; ss by #10133, eff 6-1-12; amd
by #10550, eff 4-4-14; amd by #12063, eff 12-30-16;
ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A 1402.03 Additional Exemptions for Certain Air
Contaminants. As authorized by RSA
125-I:3, III(c), the following emissions shall be exempt from this chapter:
(a) Emissions
of a hazardous air pollutant (HAP), as defined in Env-A 103, from a process or
device, provided that process or device uses the requisite pollution control
equipment to comply with a national emission standard for HAPs as codified in
40 CFR 61 or 40 CFR 63;
(b) RTAP
emissions from the process or device specified in (a), above, that are
controlled by the requisite pollution control equipment to the same degree of
efficiency as required by the national emission standard for the HAP emitted
from that process or device;
(c) HAP
emissions from a solid waste incineration unit that is subject to rules or
plans authorized by, and adopted in accordance with, §129 of the Act, provided
the unit uses the pollution control equipment required to comply with those
rules or plans; and
(d) RTAP
emissions from the solid waste incineration unit specified in (c), above, that
are controlled to the same degree of efficiency as required by the rule or plan
for the HAP emitted from that unit.
Source. #10133, eff 6-1-12; ss by #10550, eff 4-4-14;
ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
PART Env-A 1403 COMPLIANCE STANDARDS
Env-A
1403.01 Compliance with Ambient Air Limits Required.
(a) The owner or operator of any process or
device at a stationary source subject to this chapter shall manage emissions of
RTAPs such that the concentrations of RTAPs in ambient air resulting from those
emissions shall not exceed the AALs for those RTAPs at and beyond the
compliance boundary for the stationary source.
(b) If the department revises the list of RTAPs
or their respective AALs as set forth in Table 1450-1 in Env-A 1450.01, or
revises compliance boundary criteria as set forth in Env-A 1404.07, the owner
or operator of an existing stationary source, process or device shall comply
with (a) above for any revised AAL, RTAP or compliance boundary either:
(1) Within 90
days of notice of such final revision in the New Hampshire Rulemaking Register;
or
(2) On the
schedule of a compliance plan approved in accordance with Env-A 1406.02.
Source. #13334, eff 2-3-22
Env-A 1403.02 Demonstration
of Compliance with Ambient Air Limits Required.
(a) The
owner or operator of a device or process at a stationary source shall
demonstrate compliance with the AALs using one of the methods described in
Env-A 1404.
(b) If the
department revises the list of RTAPs or their respective AALs as set forth in
Table 1450-1 in Env-A 1450.01, and the owner or operator of an existing process
or device cannot demonstrate compliance with the revised list of RTAPs or their
respective AALs, then the owner or operator shall comply with Env-A 1405.04 and
Env-A 1406.02.
Source. #9601, eff 11-25-09; ss by #12443, eff 1-5-18;
ss by #13334, eff 2-3-22
PART
Env-A 1404 METHODS OF DEMONSTRATING
COMPLIANCE
Env-A 1404.01 Methods of Demonstrating Compliance. The owner or operator of any device or
process that emits a RTAP shall demonstrate compliance
with the AALs by using at least one of the following methods:
(a) Air dispersion modeling analysis as
specified in Env-A 1404.02;
(b) De
minimis emission level method as specified in Env-A 1404.03;
(c) In-stack concentration method as specified
in Env-A 1404.04;
(d) Adjusted in-stack concentration method as
specified in Env-A 1404.05; or
(e) Calculations, results, or analyses from an
alternative method of compliance demonstration approved pursuant to Env-A 1404.06.
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97;
ss and moved by #8278, eff 2-4-05 (from Env-A 1406.01); ss by #9601, eff
11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22 (formerly Env-A
1405.01)
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97;
ss by #7859, eff 4-11-03; ss and moved by #8278, eff 2-4-05 (from Env-A
1406.02); ss by #9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334,
eff 2-3-22 (formerly Env-A 1405.02)
Env-A 1404.03 De Minimis Emission Level
Method.
(a) If the de minimis emission level method is selected, the owner or
operator shall demonstrate that the emissions of each RTAP are equal to or
below the appropriate de minimis
level from Table 1450-1 in Env-A 1450.01; and
(b) The
de minimis emission level method shall only be allowed when the
airflow exiting the vent or stack is vertical and unobstructed.
Source. #8278, eff 2-4-05
(from Env-A 1406.03); ss by #9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss
by #13334, eff 2-3-22 (formerly Env-A 1405.03)
Env-A 1404.04 In-stack Concentration Method. If the in-stack concentration method is
selected, the owner or operator shall use the following equations to calculate
that
the emissions of each RTAP is equal to or below the corresponding AAL,
where:
(a) “X”
means:
(1) For devices or processes emitting from one
stack, the emission rate of each RTAP in pounds per hour (lbs/hr); or
(2) For devices or processes emitting from more
than one stack, the sum of emission rates of each RTAP from each stack in lbs/hr;
(b) “Y”
means the emission rate of each RTAP in grams per second (g/sec) as
determined by dividing X by 7.94, as shown in the formula below:
Y (g/sec)
= X (lbs/hr) / 7.94
(c) “Z”
means the emission rate of each RTAP in micrograms per second (μg/sec) as determined by multiplying Y by
106, as shown in the formula below:
Z (μg/sec) =
Y (g/sec) x 106
(d) “A”
means:
(1) For devices or processes emitting from one
stack, the stack volume flow in actual cubic feet per minute (ft3/min);
or
(2) For devices or processes emitting from more
than one stack, the sum of stack volume flows from each stack in actual ft3/min;
(e) “B”
means the stack volume flow in actual cubic meters per second (m3/sec)
as determined by dividing A by 2119, as shown in the formula below:
B (m3/sec)
= A (ft3/min) /
2119
(f) The
in-stack concentration of each RTAP in micrograms per cubic meter (μg/m3) from
a device or process either emitting from a single stack or from more than one
stack shall be calculated by dividing Z by B, as shown in the formula below:
In-stack Concentration (μg/m3) = Z (μg/sec) / B (m3/sec)
Source. #8278, eff 2-4-05
(from Env-A 1406.04); ss by #9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss
by #13334, eff 2-3-22 (formerly Env-A 1405.04)
Env-A 1404.05 Adjusted In-stack Concentration Method.
(a) If
the adjusted in-stack concentration method is selected, the owner or operator
shall demonstrate that the adjusted in-stack concentration of the RTAP, as
determined using the calculations in (c) or (d) below, is equal to or below the
corresponding AAL.
(b) The
adjusted in-stack concentration method shall only be allowed when
the airflow exiting the vent or stack is vertical and unobstructed.
(c) For
facilities where the edge of the building housing the process or device is less
than 40 feet to the nearest compliance boundary, the adjusted in-stack
concentration in μg/m3 of
an RTAP from a device or process emitting either from a single stack
or from more than one stack shall be calculated by dividing the in-stack
concentration in μg/m3,
determined in accordance with Env-A 1404.04, by 250, as shown
in the formula below:
Adjusted
In-stack Concentration (μg/m3) = In-stack
Concentration (μg/m3)
250
(d) For
facilities where the edge of the building housing the process or device is
greater than or equal to 40 feet to the nearest compliance boundary, the
adjusted in-stack concentration in μg/m3 of
an RTAP from a device or process emitting either from a single stack or from
more than one stack shall be calculated by dividing the in-stack concentration
in μg/m3, determined in accordance
with Env-A 1404.04, by 700, as shown in the formula
below:
Adjusted
In-stack Concentration (μg/m3) = In-stack
Concentration (μg/m3)
700
Source. #8278, eff 2-4-05
(from Env-A 1406.05); ss by #9601, eff 11-25-09; amd
by #9865, eff 2-18-11; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
(formerly Env-A 1405.05)
Env-A 1404.06 Alternative Methods.
(a) Any
person wishing to use a method for demonstrating compliance other than
one specified in Env-A 1404.02 through Env-A 1404.05 shall submit a written
proposal to the department for approval of the method as specified in
(b), below.
(b) The
proposal shall contain, at a minimum, the following information:
(1) The identity, location, and description of
the facility at which the alternative method is proposed to be used;
(2) A description of the proposed alternative method
and a description of each device or process to which the proposed alternative method
will be applied;
(3) The name and chemical abstracts
service (CAS) registry number for each RTAP emitted from each device or process
subject to Env-A 1400 to be assessed under the alternative method; and
(4) Technical data and information to be used to
demonstrate that:
a. The proposed alternative method would produce
results that are at least as precise and accurate as those produced by the
methods specified in Env-A 1404.02 through Env-A 1404.05; and
b. The concentration of each RTAP is less than
or equal to the corresponding AAL.
(c) Within
60 days of receipt of a complete proposal, the department shall issue a written decision
on the proposal. If the request is
denied, the decision shall specify the reason(s) for the denial.
(d) The
department shall not approve a proposal for use of an alternative method
unless:
(1) The request contains all
of the information required by (b), above; and
(2) The proposed alternate method produces
results that are at least as precise and accurate as those produced by the
methods specified in Env-A 1404.02 through Env-A 1404.05.
Source. #8278, eff 2-4-05
(from Env-A 1406.06); ss by #9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss
by #13334, eff 2-3-22 (formerly Env-A 1405.06)
Env-A
1404.07 Compliance with Compliance
Boundaries; Alternate Compliance Boundaries.
(a) A source shall comply with:
(1) The
property boundaries as established in the statutorily-defined
compliance boundary in Env-A 1401.03, if the provisions of (b) or (c) below do
not apply;
(2)
The boundary established pursuant to (b) or (c), below, if applicable;
or
(3) The
source-specific boundary determined pursuant to (d), below.
(b) For a stationary source operating
a process or device located in a building or premises pursuant
to a lease, license, or any other agreement granting the right to use or occupy
only a limited portion of the property upon which such process or device is located,
the compliance boundary shall be the outer edge of that portion of the property
under the direct control of the owner or operator of that stationary source.
(c) The owner or operator of a process or device
at a stationary source subject to this chapter shall consider any part of the
property that is leased to another entity either through a lease, license, or
other agreement, as being beyond the compliance boundary.
(d) An owner or operator wishing to use a
compliance boundary other than the boundary of the property on which the
stationary source is located, or as described in (b) or (c), above, shall
submit a written request to the department for approval of an alternate
compliance boundary which includes, at a minimum, the following information:
(1) The identity, location, and
description of the facility at which the alternate compliance boundary is
proposed to be used;
(2) A description of the
proposed alternate compliance boundary;
(3) The name and CAS registry
number for each RTAP emitted from each process or device subject to this
chapter to be assessed using the alternative compliance boundary; and
(4) Records demonstrating
compliance in accordance with Env-A 1404, based upon the proposed alternate
compliance boundary.
(e) Within 60 days of receipt of a complete
request, the department shall make a decision on the
request.
(f) The department shall approve a request for
use of an alternate compliance boundary if:
(1) The request contains all of the information required by (d), above; and
(2) The proposed alternate
compliance boundary would pose little risk to public health, in accordance with
RSA 125-I:3, III(c).
(g) If the request is denied, the decision shall
specify the reason(s) for the denial.
Source. #12443, eff 1-5-18;
ss by #13334, eff 2-3-22 (formerly Env-A 1405.07)
PART
Env-A 1405 PERMIT REQUIRED
Env-A 1405.01 Permit Required. Except as provided in Env-A 1405.02, the
owner or operator of a device or process subject to this chapter shall obtain a
temporary permit, state permit to operate, or title V operating permit in
accordance with Env-A 600, which specifies the conditions under which compliance
with this chapter shall be maintained.
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97; repealed and reserved by
#7859, eff 4-11-03
New.
#8278, eff 2-4-05 (from Env-A 1404.01); ss by #9601,
eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22 (formerly
Env-A 1403.01)
Env-A 1405.02 Exemption from Permit Requirement Based on
Nature and Amount of Emissions.
(a) The
owner or operator of any device or process shall not be required to obtain a
permit under this chapter if facility-wide emissions of each
RTAP meets one of the following conditions:
(1) The uncontrolled emissions:
a. Are less than or equal to the applicable
annual and 24-hour de minimis emission levels, using the de
minimis emission level method described in Env-A 1404.03; or
b. Result in concentrations less than or equal
to the applicable annual and 24-hour AALs using one of the methods described in
Env-A 1404.02, Env-A 1404.04, Env-A 1404.05, or Env-A 1404.06, at and beyond
the compliance boundary; or
(2) The uncontrolled actual emissions:
a. Are less than or equal to the applicable annual
and 24-hour de minimis
emission levels, using the de minimis
emission level method described in Env-A 1404.03;
b. Result in concentrations less than or equal to
the applicable annual and 24-hour AALs using the in-stack concentration
method described in Env-A 1404.04; or
c. Result in concentrations less than or equal to 50
percent of the applicable annual and 24-hour AALs using one
of
the methods described in Env-A 1404.02, Env-A 1404.05, or Env-A 1404.06
at and beyond the compliance boundary.
(b) For purposes of this part, spray
coating operations that demonstrate compliance with the spray booth filter
provisions in 40 CFR 63.11173(e)(2)(i), subpart
HHHHHH, “National Emission Standards for Hazardous Air Pollutants: Paint
Stripping and Miscellaneous Surface Coating Operations at Area Sources”, shall
not be considered control devices for the purposes of calculating emissions of
particulate RTAPs.
Source. #9601, eff 11-25-09;
ss by #10550, eff 4-4-14; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
(formerly Env-A 1403.03)
Env-A 1405.03 Obtaining a Permit. Except as provided in Env-A 1405.04, the
owner or operator of a process or device at a stationary source subject to this
chapter, that requires a permit pursuant to Env-A 1405.01 shall obtain such a
permit in accordance with Env-A 603.
Source. #13334, eff 2-3-22
Env-A
1405.04 Revision of List or
Compliance Boundary by Department.
If the department revises the list of RTAPs, their respective AALs, or
compliance boundary in accordance with Env-A 1404.07(b) or (c) and as a result
of such revision the owner or operator is required to obtain or modify a
permit, the owner or operator shall file a complete application for such permit
or permit modification, including a compliance plan, within 90 days of
publication of such notice of final revision in the New Hampshire Rulemaking
Register.
Source. #13334, eff 2-3-22
PART Env-A 1406 APPLICATION PROCEDURES
Env-A 1406.01 Application
Procedures for New or Modified Devices or Processes.
(a) The
owner or operator of a new or modified device or process requiring a permit
under this chapter shall submit an application for a temporary permit in
accordance with Env-A 607.03, and identify in detail
the proposed operating conditions that the source will take to comply with the
AALs, in accordance with Env-A 1403.
(b) Pursuant to RSA 125-I:5, I, the owner or operator shall not operate the device or process
until a temporary permit is issued.
Source. #6468-B, eff 3-5-97;
amd by #6739-B, eff 5-8-98; amd
by #7859, eff 4-11-03; amd by #8095, eff 6-11-04; ss
and moved by #8278, eff 2-4-05 (from Env-A 1405.01); ss by #9601, eff 11-25-09;
ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22 (formerly Env-A 1404.01)
Env-A 1406.02 Application Procedures for Existing
Sources Requiring a Permit after the List is Revised. If a permit is required to be obtained or
modified in accordance with Env-A 1405.04, the owner or operator of such
source shall:
(a) File an application for such permit
or permit modification, in accordance with Env-A 612, within 90 days following
publication of notice of such final revision in the New Hampshire Rulemaking
Register; and
(b) Submit a compliance plan based on public
health, and economic and technical considerations that shall contain, at a
minimum, the following information:
(1) The name
and CAS registry number for each RTAP emitted from each process or device
subject to the compliance plan;
(2) The date
upon which compliance with the applicable provisions will be achieved, which
shall be no later than 3 years following publication of notice of such final
revisions in the New Hampshire Rulemaking Register;
(3) A list of
remedial measures, including the sequence of actions or operations with
milestones for each action; and
(4) A schedule
for the submission of progress reports to the department.
Source. #8278, eff 2-4-05
(from Env-A 1405.02); ss by #9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss
by #13334, eff 2-3-22 (formerly Env-A 1404.02)
PART
Env-A 1407 CLASSIFICATION OF REGULATED
TOXIC AIR POLLUTANTS
Env-A
1407.01 Classification of Regulated
Toxic Air Pollutants.
(a) As
required
by RSA 125-I:4, II, the department shall classify each RTAP as a class I RTAP, class
II RTAP, or class III RTAP.
(b) Such
classifications
shall be made in accordance with this part.
Source. #6468-B, eff 3-5-97;
ss and moved by #8278, eff 2-4-05 (from Env-A 1407.01); ss by #9601, eff
11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22 (formerly Env-A
1406.01)
Env-A 1407.02 Criteria for Classification of Class I
Regulated Toxic Air Pollutants. The
department shall classify an RTAP as a class I RTAP if
it meets at least one of the following criteria:
(a) Pursuant
to RSA 125-I:2, XIV(a), it is a group A, group B1, or group B2 carcinogen, as
described in “Guidelines for Carcinogen Risk Assessment,” 51 Federal Register
33,992, at 34,000 (Sept. 24, 1986);
(b) It
is categorized as “Carcinogenic to Humans” or “Likely to be Carcinogenic to
Humans” as described in EPA’s updated “Guidelines for Carcinogenic Risk
Assessment,” 70 Federal Register 17765 to 17817 (April 7, 2005);
(c) It
is a category A1 or A2 carcinogen, as described in Threshold Limit Values
for Chemical Substances and Physical Agents and Biological Exposure Indices,
published by the American Conference of Governmental Industrial Hygienists
(ACGIH);
(d) It
has been demonstrated through at least one study conducted in accordance with
generally accepted scientific principles that it is capable of inducing
reproductive or developmental effects in experimental laboratory animals at
doses less than or equal to 500 mg/kg; or
(e) It
has an acute toxicity where the:
(1) Oral
LD50
is less than or equal to 50 milligrams per kilogram of body weight (mg/kg);
(2) Inhalation
LC50 is less than or equal to 200 parts per million (ppm); or
(3) Dermal
LD50 is less than or equal to 200 mg/kg.
Source. #6468-B, eff 3-5-97;
ss by #7859, eff 4-11-03; ss and moved by #8278, eff 2-4-05 (from Env-A
1407.02); ss by #9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334,
eff 2-3-22 (formerly Env-A 1406.02)
Env-A
1407.03 Criteria for Classification
of Class II Regulated Toxic Air Pollutants.
The department shall classify an RTAP as a class II RTAP if
it does not qualify as a class I regulated toxic air
pollutant and meets at least one of the following criteria:
(a) Pursuant
to RSA 125-I:2, XIV(b), it is a group C carcinogen, as described in “Guidelines
for Carcinogen Risk Assessment,” 51 Federal Register 33,992, at 34,000 (Sept.
24, 1986);
(b) It
is categorized as “Suggestive Evidence of Carcinogenic Potential” as described
in EPA’s updated “Guidelines for Carcinogenic Risk Assessment,” 70 Federal
Register 17765 to 17817, April 7, 2005;
(c) It
is a category A3 carcinogen, as described in Threshold Limit Values for
Chemical Substances and Physical Agents and Biological Exposure Indices,
published by the ACGIH;
(d) It
has been demonstrated through at least one study conducted in accordance with
generally accepted scientific principles that it is capable of inducing
reproductive or developmental effects in experimental laboratory animals at
doses greater than 500 mg/kg;
(e) It
has an acute toxicity where the:
(1) Oral
LD50 is greater than 50 mg/kg but less than 500 mg/kg;
(2) Inhalation
LC50 is greater than 200 ppm but less than 2,000 ppm;
or
(3) Dermal
LD50 is greater than 200 mg/kg but less than 1,000 mg/kg;
(f) It
has been demonstrated through at least one study conducted in accordance with
generally accepted scientific principles that it induces mutagenic effects; or
(g) It
has been demonstrated through at least one study
conducted in accordance with generally accepted scientific principles that it
produces adverse chronic non-carcinogenic systemic effects.
Source. #6468-B, eff 3-5-97;
ss by #6739-B, eff 5-8-98; ss by #7859, eff 4-11-03; ss and moved by #8278, eff
2-4-05 (from Env-A 1407.03); ss by #9601, eff 11-25-09; ss by #12443, eff
1-5-18; ss by #13334, eff 2-3-22 (formerly Env-A 1406.03)
Env-A 1407.04 Criteria for Classification of Class III
Regulated Toxic Air Pollutants. As
specified in RSA 125-I: 2, XIV(c), the department shall classify a RTAP as
a class III regulated toxic air pollutant if it is any RTAP other than a class I or
class II RTAP.
Source. #6468-B, eff 3-5-97;
ss and moved by #6739-B, eff 5-8-98 (from Env-A 1406.03); ss by #7616, eff
12-28-01; amd by #7859, eff 4-11-03; ss and moved by
#8278, eff 2-4-05 (from Env-A 1407.04); ss by #9601, eff 11-25-09; ss by
#12443, eff 1-5-18; ss by #13334, eff 2-3-22 (formerly Env-A 1406.04)
PART Env-A 1408 SAFETY FACTORS; TIME ADJUSTMENT FACTORS
Env-A 1408.01 Designation of Safety Factors. For the purpose of
providing adequate protection to sensitive populations, the department shall
designate a safety factor for each RTAP, as follows:
(a) For
a class I RTAP, the safety factor shall be 100;
(b) For
a class II RTAP, the safety factor shall be 71; and
(c) For
a class III RTAP, the safety factor shall be 24.
Source. #6468-B, eff 3-5-97;
ss and moved by #8278, eff 2-4-05 (from Env-A 1408.01); ss by #9601, eff
11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22 (formerly Env-A
1407.01)
Env-A 1408.02 Designation of Time Adjustment Factors.
(a) In
order to account for differing effects of certain chemicals over time, the
department shall designate a time adjustment factor according to the
characteristics of the RTAP, as described in Env-A 1408.03.
(b) The
time adjustment factor shall be used to determine the AAL as specified in Env-A 1409.02.
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
Source. #6468-B, eff 3-5-97;
ss and moved by #8278, eff 2-4-05 (from Env-A 1409.02); ss by #9601, eff
11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22 (formerly Env-A
1408.01)
Env-A 1408.03 Criteria for the Designation of Time
Adjustment Factors. The department
shall designate the time adjustment factors based on the following criteria:
(a) The
time adjustment factor shall be 1.0 for
RTAPs
that:
(1) Have
an occupational exposure limit that is intended to primarily prevent
irritation or discomfort; or
(2) For
which there are essentially no known cumulative effects resulting from extended
exposures to such pollutants at
concentration levels at or near the occupational exposure limit;
(b) The
time adjustment factor shall be 2.0 for RTAPs that have an
occupational exposure limit that is intended to prevent acute
exposure effects;
(c) The time
adjustment factor shall be 2.5 for RTAPs that have a ceiling limit value set
as an occupational exposure limit that is not intended to be exceeded at any
time; and
(d) The
time adjustment factor shall be 2.8 for RTAPs that:
(1) Have
an occupational exposure limit that is set by technological feasibility
or commonly recognized good hygiene practice;
(2) Present
cumulative health hazards
and have an occupational exposure limit intended to prevent excessive
accumulation in the body from extended periods of exposure; or
(3) Present
both acute and cumulative health hazards.
Source. #6468-B, eff 3-5-97; ss and moved by #8278,
eff 2-4-05 (from Env-A 1409.02); ss by #9601, eff 11-25-09; ss by #12443, eff
1-5-18; ss by #13334, eff 2-3-22 (formerly Env-A 1408.02)
PART
Env-A 1409 DETERMINATION OF 24-HOUR
AMBIENT AIR LIMITS
Env-A 1409.01 Determination of 24-Hour Ambient Air
Limits.
(a) Where a reference concentration limit has
been established by the EPA for an RTAP, the 24-hour AAL for that pollutant shall
be the reference concentration limit if:
(1) The RTAP
causes developmental or reproductive effects; or
(2) The
annual AAL is based on the reference concentration limit, and the
24-hour AAL, as calculated in accordance with (b), below, is less than the
reference concentration limit.
(b) In all cases other than those specified in (a),
above, the 24-hour AAL shall be a modified occupational health standard as determined by the
calculation specified in Env-A 1409.02.
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97; ss and moved by #8278,
eff 2-4-05 (from Env-A 1410.01); ss by #9601, eff 11-25-09; ss by #12443, eff
1-5-18; ss by #13334, eff 2-3-22
Env-A 1409.02 Calculation of 24-Hour Ambient Air Limits.
(a) “OEL”
means the occupational exposure limit for the RTAP.
(b) “SF”
means the safety factor as determined by Env-A 1408.01.
(c) “TAF”
means the time adjustment factor as determined by Env-A 1408.02.
(d) To
calculate the 24-hour AAL for an RTAP,
occupational exposure limit shall be divided by the product of the safety
factor and the time adjustment factor, as in the formula below:
AAL(24 Hour) =
OEL / (SF x TAF)
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97; ss by #6739-B, eff
5-8-98; ss and moved by #8278, eff 2-4-05 (from Env-A 1410.02); ss by #9601,
eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
PART
Env-A 1410 DETERMINATION OF ANNUAL
AMBIENT AIR LIMITS
Env-A 1410.01 Determination of Annual Ambient Air Limits.
(a) Where
there is a reference concentration limit established by the EPA, the
annual AAL shall be the reference concentration limit, except as provided
in (b), below.
(b) Where an RTAP has a reference concentration
limit established by the EPA and is classified as Class I under Env-A 1407.02(a) or
(b), and the occupational exposure limit is based on carcinogenic effects, the annual AAL
shall be either a modified occupational health standard as
determined by the calculation specified in Env-A 1410.02, or the
reference concentration limit established by the EPA, whichever number is
lower.
(c) Where
there is no reference concentration limit, the annual AAL shall be a modified
occupational health standard as determined by the calculation specified in
Env-A 1410.02.
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97; ss by #8095, eff
6-11-04; ss and moved by #8278, eff 2-4-05 (from Env-A 1411.01); ss by #9601,
eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A 1410.02 Calculation of Annual Ambient Air Limits.
(a) “OEL”
means the occupational exposure limit
for the RTAP.
(b) “SF”
means the safety factor as determined by Env-A 1408.01.
(c) To
calculate the annual AAL for an RTAP, the
occupational exposure limit shall be
divided by the product of 4.2 and the safety factor, as in the formula below:
AAL(Annual) =
OEL / (SF x 4.2)
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97; amd
by #6739-B, eff 5-8-98; ss and moved by #8278, eff 2-4-05 (from Env-A 1411.02);
ss by #9601, eff 11-25-09; ss by #10550, eff 4-4-14; ss by #12443, eff 1-5-18;
ss by #13334, eff 2-3-22
Env-A 1410.03 Calculation of 24-Hour De Minimis Emission Level. To calculate the 24-hour de minimis emission level for an
RTAP
in pounds per day, the 24-hour AAL shall be divided by 84.17.
Source. #8278, eff 2-4-05 (from Env-A 1411.03); ss by
#9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A 1410.04 Calculation of Annual De Minimis Emission Level.
The annual de minimis
emission level for an RTAP in pounds per year shall be the
lower of the levels calculated pursuant to (a) or (b), below:
(a) The
annual AAL multiplied by 16.28; or
(b) The
24-hour de minimis
emission level multiplied by 365.
Source. #8278, eff 2-4-05 (from Env-A 1411.04); ss by
#9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
PART Env-A 1411 LIST OF ALL REGULATED TOXIC AIR POLLUTANTS AND
OTHER INFORMATION
Env-A 1411.01 Establishment of List of All Regulated
Toxic Air Pollutants and Other Information.
(a) The
list established by the department pursuant to RSA 125-I:6, II, shall contain
the following information for each RTAP:
(1) The
chemical name of the RTAP;
(2) The
chemical abstracts service number of the RTAP;
(3) The
classification as class I, class II, or class III for the RTAP;
(4) The
24-hour AAL for the RTAP;
(5) The
annual
AAL
for the RTAP;
(6) The
24-hour de minimis
emission level for the RTAP; and
(7) The
annual de minimis
emission level for the RTAP.
(b) The
RTAP list described in (a), above, shall be adopted and published in table
format in Env-A 1450.
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97; ss by #8095, eff
6-11-04; ss and moved by #8278, eff 2-4-05 (from Env-A 1412.01); ss by #9601,
eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A
1411.02 Adoption of the RTAP List. The RTAP list described in Env-A 1411.01
shall be adopted according to the rulemaking process specified in RSA 541-A.
Source. #6328, INTERIM, eff 8-24-96, EXPIRED: 12-22-96
New. #6468-B, eff 3-5-97; amd
by #6739-B, eff 5-8-98; ss and moved by #8278, eff 2-4-05 (from Env-A 1412.02);
ss by #9601, eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A
1411.03 Publication of Notice of the
RTAP List.
(a) As required by RSA 125-I:4, IV, the
department shall submit notice of the RTAP list for publication in the New
Hampshire Rulemaking Register and any revisions to the list shall
not take effect until such publication.
(b) At
that time, and annually thereafter, the department shall publish the list on the
department’s website.
(c) The department shall make the list available
to any person who requests it.
Source. #6739-B, eff 5-8-98; ss by #7859, eff
4-11-03; ss and moved by #8278, eff 2-4-05 (from Env-A 1412.03); ss by #9601,
eff 11-25-09; ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
PART
Env-A 1412 MODIFICATION OF THE RTAP LIST
Env-A 1412.01 Process for Modifications to the RTAP List. As specified in RSA 125-I:4, V, all
additions, deletions and modifications to any part of
the RTAP list shall be made through the rulemaking process described in RSA
541-A.
Source. #6468-B, eff 3-5-97; ss by #6739-B, eff
5-8-98; amd by #7859, eff 4-11-03; ss and moved by
#8278, eff 2-4-05 (from Env-A 1413.01); ss by #9601, eff 11-25-09; ss by
#12443, eff 1-5-18; ss by #13334, eff 2-3-22
Env-A 1412.02 Petitions to Modify the RTAP List.
(a) If
a person wishes to add a substance or compound to, delete a substance or
compound from, or modify a specific parameter on the RTAP list, the person
shall petition the commissioner pursuant to RSA 541-A:4 and Env-C 207 by
providing the information specified in Env-A 1412.03 in writing to the
commissioner.
(b) Where
data limitations exist which prevent the derivation of an AAL, a person
intending to use a substance
or compound named on the list shall petition the commissioner by providing the
information specified in Env-A 1412.03 in writing to the commissioner.
Source. #6468-B, eff 3-5-97; ss and moved by #8278,
eff 2-4-05 (from Env-A 1413.02); ss by #9601, eff 11-25-09; ss by #12443, eff
1-5-18; ss by #13334, eff 2-3-22
Env-A 1412.03 Contents of Petitions. A petition submitted pursuant to Env-A 1412.02(a)
or (b) shall include the following information:
(a) Which one or more of the following actions
is proposed:
(1) Add
a substance or compound to the RTAP list;
(2) Delete
a substance or compound from the RTAP list;
(3) Modify
the classification of a RTAP named on the list;
(4) Modify
or add an AAL of a RTAP named on the list;
(5) Modify
a time adjustment factor of a RTAP named on the list;
(6) Modify
an occupational exposure limit of a RTAP named on the list; or
(7) Modify
a de minimis emission
level of a RTAP named on the list;
(b) A
statement of the reason(s) for the proposed revision to the RTAP list;
(c) If
the proposal is to add a substance or compound to the RTAP list, data and
documentation that support the proposed addition, including at least one study
that has been conducted in accordance with generally accepted scientific
principles which demonstrates that the substance or compound is known to cause,
or can reasonably be anticipated to cause, acute, chronic, mutagenic,
reproductive, or developmental health effects in humans as a result of exposure
to such substance or compound;
(d) If
the proposal is to delete a substance or compound from the RTAP list, data and
documentation that support the proposed deletion, including at least one study
that has been conducted in accordance with generally accepted scientific
principles which demonstrates that the substance or compound cannot reasonably
be anticipated to cause acute,
chronic, mutagenic, reproductive, or developmental health effects in
humans as a result of exposure to such substance or compound; and
(e) If
the proposal is to modify a parameter for a substance or compound on the RTAP
list, data and documentation that support the proposed modification, including
at least one study that has been conducted in accordance with generally
accepted scientific principles which demonstrates that:
(1) If
the petition is for stricter regulatory control of a substance or compound, the
parameter specified in the RTAP list is not adequate to protect against acute,
chronic, mutagenic, reproductive, or developmental health effects in humans as a result of exposure to the substance or compound; or
(2) If the petition is for more lenient
regulatory control of a substance or compound, the parameter specified in the
RTAP list is more stringent than is necessary to protect against acute,
chronic, mutagenic, reproductive, or developmental health effects in humans as a result of exposure to the substance or compound.
Source. #6468-B, eff 3-5-97; ss and moved by #8278,
eff 2-4-05 (from Env-A 1413.03); ss by #9601, eff 11-25-09; ss by #12443, eff
1-5-18; ss by #13334, eff 2-3-22
Env-A 1412.04 Decision to Grant or Deny the Petition.
(a) The
commissioner shall act on the petition within the time limits specified in RSA
541-A:4.
(b) As
specified in RSA 125-I:4, V(a), the commissioner shall not add a substance or
compound to the RTAP list unless there is at least one study that has been
conducted in accordance with generally accepted scientific principles that
demonstrates that the substance or compound is known to cause or may reasonably
be anticipated to cause acute, chronic, mutagenic, reproductive, or
developmental health effects in humans as a result of exposure to such
substances or compounds.
(c) As
specified in RSA 125-I:4, V(b), the commissioner shall not delete a substance
or compound from the RTAP list unless there is at least one study that has been
conducted in accordance with generally accepted scientific principles that
demonstrates that the substance or compound cannot reasonably be anticipated to
cause acute, chronic, mutagenic, reproductive, or developmental health effects
in humans as a result of exposure to such substances or compounds.
(d) In
addition to the criteria specified in (b) or (c), above, as applicable, the
commissioner shall not grant a petition unless doing so will result in
standards that promote human health.
Source. #9601, eff 11-25-09;
ss by #12443, eff 1-5-18; ss by #13334, eff 2-3-22
PART Env-A 1413 REQUIREMENTS FOR SOURCES OF HAZARDOUS AIR
POLLUTANTS SUBJECT TO SECTION 112 OF THE CLEAN AIR ACT
Env-A 1413.01 Sources of Hazardous Air Pollutants
Subject to §112
of the Act.
Nothing in this chapter shall be construed as modifying or eliminating
the obligation of any source of hazardous air pollutants that is subject to §112
of the Clean Air Act to comply with those requirements.
Source. #6468-B, eff 3-5-97; ss and moved by #8278,
eff 2-4-05 (from Env-A 1414.01); ss by #9601, eff 11-25-09; ss by #12443, eff
1-5-18; ss by #13334, eff 2-3-22
PART Env-A 1414 - RESERVED
Source. #6468-B, eff 3-5-97;
moved by #8278 (See Env-A 1413)
PARTS Env-A 1415 - 1449 - RESERVED
PART
Env-A 1450 TABLE
OF ALL REGULATED TOXIC AIR POLLUTANTS
Env-A 1450.01 Table of All Regulated Toxic Air Pollutants.
(a) The
AALs and de minimis values for “wood dust (western red
cedar),” “wood dust (oak & beech),” “wood dust (birch, mahogany, teak,
walnut)” and “wood dust (all other species)” in Table 1450-1, below, shall
apply only to emissions from sanding operations at sources belonging to Major
Group 24 or 25 as described in the Standard Industrial Classification Manual,
1987, and assigned by EPA the following Source Classification Code (SCC)
numbers: 30700702, 30700806, 30700807,
30702003, 30703096, 30703097, 30703098, and 30703099.
(b) Pursuant
to Env-A 1411.01, the list naming all regulated toxic air pollutants and other
information shall be as set forth in Table 1450-1, below:
Table 1450-1: RTAP
List
CAS Number |
Description |
Toxicity ClassA |
24-Hr AAL
(µg/m3) |
Annual AALB (µg/m3) |
24-Hr De MinimisC (lbs/day) |
Annual De Minimis(lbs/yr) |
0-00-0 |
Borate
compounds, inorganic, inhalable fraction |
I |
7.1 |
4.8 |
0.084 |
31 |
0
– 00 – 0 |
Coal Dust
(anthracite), respirable fraction |
II |
2.0 |
1.3 |
0.024 |
8.7 |
0
– 00 – 0 |
Coal
Dust (bituminous), respirable fraction |
II |
4.5 |
3.0 |
0.053 |
20 |
0
– 00 – 0 |
Fluorides,
as F |
I |
8.9 |
6.0 |
0.11 |
39 |
0
– 00 – 0 |
Grain
Dust (Oat, Wheat, Barley) |
II |
20 |
13 |
0.24 |
87 |
0-00-0 |
Methyltetrahydrophthalic
anhydride isomers |
II |
0.0025 |
0.0017 |
0.000030 |
0.011 |
0
– 00 – 0 |
Stearates, respirable fraction |
III |
62 |
30 |
0.74 |
271 |
0-00-0 |
Stearates, inhalable fraction |
III |
208 |
99 |
2.5 |
903 |
0
– 00 – 0 |
Synthetic
vitreous fibers, Continuous Filament Glass Fiber (inhalable) |
II |
70 |
17 |
0.83 |
277 |
0
– 00 – 0 |
Wood Dust (western red cedar), inhalable fraction (See Env-A
1450.01(a)) |
II |
2.5 |
1.7 |
0.030 |
11 |
0
– 00 – 0 |
Wood Dust (oak and beech), inhalable fraction (See Env-A 1450.01(a)) |
I |
3.6 |
2.4 |
0.043 |
16 |
0
– 00 – 0 |
Wood Dust (birch, mahogany, teak, and walnut), inhalable
fraction (See Env-A 1450.01(a)) |
I |
3.6 |
2.4 |
0.043 |
16 |
0
– 00 – 0 |
Wood Dust (all other species), inhalable fraction (See Env-A
1450.01(a)) |
III |
15 |
9.9 |
0.18 |
65 |
50
– 00 – 0 |
Formaldehyde |
I |
9.8 |
1.8 |
0.12 |
29 |
50
– 29 – 3 |
DDT |
I |
3.6 |
2.4 |
0.043 |
16 |
50
– 32 – 8 |
Benzo[a]pyrene |
I |
0.0020 |
0.0020 |
0.000024 |
0.0087 |
50
– 78 – 2 |
Acetylsalicylic acid |
I |
25 |
12 |
0.30 |
108 |
52
– 68 – 6 |
Trichlorophon, inhalable
fraction |
I |
3.6 |
2.4 |
0.043 |
16 |
55
– 38 – 9 |
Fenthion –
inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
55
– 63 – 0 |
Nitroglycerin (NG) |
I |
1.6 |
1.1 |
0.019 |
6.9 |
56 – 23 –
5 |
Carbon
tetrachloride |
I |
111 |
100 |
1.3 |
481 |
56
– 38 – 2 |
Parathion, inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
56
– 55 – 3 |
Benz[a]anthracene |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
56 – 72 – 4 |
Coumaphos – inhalable
fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
57-11-4 |
Stearic acid inhalable fraction (see
Stearates, inhalable fraction, CAS# 0-00-0) |
|
|
|
|
|
57-11-4 |
Stearic acid, respirable fraction (see Stearates, respirable
fraction, CAS# 0-00-0) |
|
|
|
|
|
57
– 14 – 7 |
1,1-Dimethylhydrazine |
I |
0.089 |
0.060 |
0.0011 |
0.39 |
57
– 24 – 9 |
Strychnine |
I |
0.54 |
0.36 |
0.0064 |
2.3 |
57
– 57 – 8 |
Β -Propiolactone |
I |
7.5 |
3.6 |
0.089 |
33 |
57
– 74 – 9 |
Chlordane, inhalable fraction and vapor |
I |
1.8 |
0.70 |
0.021 |
7.8 |
58
– 89 – 9 |
Lindane |
I |
1.8 |
1.2 |
0.021 |
7.8 |
60
– 29 – 7 |
Ethyl ether |
I |
4321 |
2881 |
51 |
18738 |
60
– 34 – 4 |
Methyl hydrazine |
I |
0.068 |
0.045 |
0.00081 |
0.29 |
60-35-5 |
Acetamide, inhalable fraction and vapor |
II |
17 |
8.1 |
0.20 |
74 |
60
– 57 – 1 |
Dieldrin,
inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0042 |
1.5 |
61
– 82 – 5 |
Amitrole |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
62
– 53 – 3 |
Aniline |
I |
27 |
1.0 |
0.32 |
16 |
62
– 73 – 7 |
Dichlorvos (DDVP), inhalable fraction and vapor |
I |
0.50 |
0.50 |
0.0059 |
2.2 |
62
– 74 – 8 |
Sodium fluoroacetate |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
62
– 75 – 9 |
N-Nitrosodimethylamine |
I |
0.00070 |
0.00070 |
0.0000083 |
0.0030 |
63
– 25 – 2 |
Carbaryl, inhalable fraction and vapor |
I |
1.8 |
1.2 |
0.021 |
7.8 |
64
– 17 – 5 |
Ethanol |
I |
6714 |
4476 |
80 |
29115 |
64
– 18 – 6 |
Formic acid |
II |
66 |
32 |
0.78 |
286 |
64
– 19 – 7 |
Acetic Acid |
II |
126 |
84 |
1.5 |
546 |
64
– 67 – 5 |
Diethyl Sulfate |
II |
1.0 |
0.67 |
0.012 |
4.4 |
67
– 56 – 1 |
Methanol |
I |
20000 |
20000 |
238 |
86729 |
67
– 63 – 0 |
2-Propanol |
I |
1757 |
1171 |
21 |
7619 |
67
– 64 – 1 |
Acetone |
I |
2120 |
1413 |
25 |
9193 |
67
– 66 – 3 |
Chloroform |
I |
175 |
117 |
2.1 |
759 |
67
– 72 – 1 |
Hexachloroethane |
I |
35 |
30 |
0.42 |
152 |
68
– 11 – 1 |
Thioglycolic acid |
I |
14 |
9.0 |
0.16 |
58 |
68
– 12 – 2 |
Dimethylformamide |
I |
53 |
30 |
0.63 |
232 |
71
– 23 – 8 |
n-Propyl alcohol |
II |
1731 |
824 |
21 |
7506 |
71
– 36 – 3 |
n-Butanol |
II |
305 |
203 |
3.6 |
1323 |
71
– 43 – 2 |
Benzene |
I |
5.7 |
3.8 |
0.068 |
25 |
71-48-7 |
Cobalt acetate, as Co, inhalable fraction (see Cobalt and
inorganic compounds, as Co, inhalable fraction, CAS # 7440-48-4) |
|
|
|
|
|
71
– 55 – 6 |
Methyl chloroform |
I |
6821 |
5000 |
81 |
29579 |
72
– 20 – 8 |
Endrin |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
72
– 43 – 5 |
Methoxychlor |
I |
36 |
24 |
0.43 |
156 |
74
– 83 – 9 |
Methyl bromide |
II |
20 |
5.0 |
0.24 |
81 |
74
– 87 – 3 |
Methyl chloride |
I |
368 |
90 |
4.4 |
1465 |
74
– 88 – 4 |
Methyl iodide |
II |
60 |
40 |
0.71 |
260 |
74
– 89 – 5 |
Methylamine |
II |
45 |
21 |
0.53 |
195 |
74
– 90 – 8 |
Hydrogen
cyanide, and cyanide salts, as CN |
I |
19 |
0.80 |
0.23 |
13 |
74
– 93 – 1 |
Methyl mercaptan |
II |
4.9 |
3.3 |
0.058 |
21 |
74
– 96 – 4 |
Ethyl bromide |
II |
111 |
74 |
1.3 |
481 |
74
– 97 – 5 |
Chlorobromomethane |
II |
5332 |
3555 |
63 |
23122 |
75
– 00 – 3 |
Ethyl chloride |
I |
10000 |
10000 |
119 |
43365 |
75
– 01 – 4 |
Vinyl chloride |
I |
9.3 |
6.2 |
0.11 |
40 |
75
– 02 – 5 |
Vinyl fluoride |
I |
6.8 |
4.5 |
0.081 |
29 |
75
– 04 – 7 |
Ethylamine |
II |
46 |
31 |
0.55 |
201 |
75
– 05 – 8 |
Acetonitrile |
I |
120 |
60 |
1.4 |
520 |
75
– 07 – 0 |
Acetaldehyde |
I |
161 |
9.0 |
1.9 |
147 |
75
– 08 – 1 |
Ethyl mercaptan |
II |
9.2 |
4.4 |
0.11 |
40 |
75
– 09 – 2 |
Methylene
chloride (Dichloromethane) |
I |
621 |
600 |
7.4 |
2693 |
75
– 12 – 7 |
Formamide |
II |
91 |
60 |
1.1 |
395 |
75
– 15 – 0 |
Carbon disulfide |
I |
700 |
700 |
8.3 |
3036 |
75
– 21 – 8 |
Ethylene oxide |
I |
6.4 |
4.3 |
0.076 |
28 |
75
– 25 – 2 |
Bromoform |
I |
19 |
12 |
0.23 |
82 |
75
– 31 – 0 |
Isopropylamine |
II |
85 |
40 |
1.0 |
369 |
75
– 34 – 3 |
1,1-Dichloroethane |
II |
2037 |
1358 |
24 |
8833 |
75
– 35 – 4 |
Vinylidene chloride |
II |
200 |
200 |
2.4 |
867 |
75
– 43 – 4 |
Dichlorofluoromethane |
II |
211 |
141 |
2.5 |
915 |
75
– 44 – 5 |
Phosgene |
I |
1.4 |
0.30 |
0.017 |
4.9 |
75
– 45 – 6 |
Chlorodifluoromethane |
II |
50000 |
50000 |
594 |
216823 |
75
– 47 – 8 |
Iodoform |
II |
70 |
34 |
0.83 |
304 |
75
– 50 – 3 |
Trimethylamine |
II |
60 |
40 |
0.71 |
260 |
75
– 52 – 5 |
Nitromethane |
III |
744 |
496 |
8.8 |
3226 |
75
– 55 – 8 |
Propyleneimine |
I |
1.7 |
1.1 |
0.020 |
7.2 |
75
– 56 – 9 |
Propylene oxide |
I |
17 |
11 |
0.20 |
74 |
75
– 65 – 0 |
tert-Butanol |
II |
2134 |
1016 |
25 |
9254 |
75
– 74 – 1 |
Tetramethyl lead, as Pb |
I |
0.54 |
0.36 |
0.0064 |
2.3 |
75
– 86 – 5 |
Acetone
cyanohydrin, as CN |
I |
18 |
12 |
0.21 |
78 |
75-91-2 |
Tert-Butyl
hydroperoxide |
II |
2.6 |
1.2 |
0.031 |
11 |
76
– 03 – 9 |
Trichloroacetic
acid |
I |
12 |
7.9 |
0.14 |
52 |
76
– 06 – 2 |
Chloropicrin |
I |
3.4 |
1.6 |
0.040 |
15 |
76
– 13 – 1 |
1,1,2-Trichloro-1,2,2-trifluoroethane |
II |
38581 |
25721 |
458 |
167305 |
76
– 22 – 2 |
Camphor, synthetic |
II |
85 |
40 |
1.0 |
369 |
76
– 44 – 8 |
Heptachlor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
77
– 47 – 4 |
Hexachlorocyclopentadiene (HCCPD) |
II |
0.55 |
0.20 |
0.0065 |
2.4 |
77
– 58 – 7 |
Dibutyltin dilaurate as Sn (see Tin, organic compounds, as Sn,
CAS# 7440-31-5) |
|
|
|
|
|
77
– 73 – 6 |
Dicyclopentadiene |
I |
9.7 |
6.4 |
0.12 |
42 |
77
– 78 – 1 |
Dimethyl sulfate |
I |
1.9 |
1.2 |
0.023 |
8.2 |
78
– 00 – 2 |
Tetraethyl lead, as Pb |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
78
– 30 – 8 |
Triorthocresyl phosphate, inhalable fraction and
vapor |
I |
0.071 |
0.048 |
0.00085 |
0.31 |
78
– 34 – 2 |
Dioxathion, inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
78
– 59 – 1 |
Isophorone |
II |
141 |
94 |
1.7 |
611 |
78
– 83 – 1 |
Isobutyl alcohol |
II |
765 |
510 |
9.1 |
3317 |
78 – 87 – 5 |
Propylene
dichloride (1,2-dichloropropane) |
II |
232 |
4.0 |
2.8 |
65 |
78
– 89 – 7 |
2-Chloro-1-propanol |
II |
27 |
13 |
0.32 |
117 |
78
– 92 – 2 |
sec-Butanol |
II |
2134 |
1016 |
25 |
9254 |
78
– 93 – 3 |
Methyl ethyl ketone (MEK) |
I |
5000 |
5000 |
59 |
21682 |
78
– 94 – 4 |
Methyl vinyl ketone |
I |
0.11 |
0.068 |
0.0014 |
0.050 |
78
– 95 – 5 |
Chloroacetone |
I |
15 |
9.0 |
0.18 |
65 |
79
– 00 – 5 |
1,1,2-Trichloroethane |
II |
277 |
184 |
3.3 |
1201 |
79 – 01 – 6 |
Trichloroethylene |
I |
2.0 |
2.0 |
0.024 |
8.7 |
79
– 04 – 9 |
Chloroacetyl chloride |
II |
1.6 |
0.77 |
0.019 |
6.9 |
79
– 06 – 1 |
Acrylamide,
inhalable fraction and vapor |
I |
6.0 |
6.0 |
0.071 |
26 |
79
– 09 – 4 |
Propionic acid |
II |
211 |
101 |
2.5 |
915 |
79
– 10 – 7 |
Acrylic acid |
I |
21 |
1.0 |
0.25 |
16 |
79 – 11 – 8 |
Monochloroacetic
acid (Chloroacetic acid) –inhalable fraction and vapor |
III |
29 |
19 |
0.34 |
126 |
79-21-0 |
Peracetic acid,
inhalable fraction and vapor |
I |
6.2 |
2.9 |
0.074 |
27 |
79 – 27 – 6 |
1,1,2,2-Tetrabromoethane |
I |
5.0 |
3.4 |
0.059 |
22 |
79
– 34 – 5 |
1,1,2,2-Tetrachloroethane |
I |
25 |
16 |
0.30 |
108 |
79
– 41 – 4 |
Methacrylic acid |
II |
352 |
235 |
4.2 |
1526 |
79
– 43 – 6 |
Dichloroacetic
acid |
I |
9.4 |
6.3 |
0.11 |
41 |
79
– 44 – 7 |
Dimethyl carbamoyl chloride |
I |
0.075 |
0.050 |
0.00089 |
0.33 |
79
– 46 – 9 |
2-Nitropropane |
I |
129 |
20 |
1.5 |
326 |
80
– 51 – 3 |
p,p’-oxybis(benzenesulfonyl
hydrazide), inhalable fraction |
III |
4.2 |
0.99 |
0.050 |
16 |
80
– 56 – 8 |
α - Pinene (see Turpentine and select
monoterpenes, CAS# 8006-64-2) |
|
|
|
|
|
80
– 62 – 6 |
Methyl methacrylate |
I |
732 |
700 |
8.7 |
3174 |
81
– 81 – 2 |
Warfarin, inhalable fraction |
I |
0.036 |
0.024 |
0.00042 |
0.15 |
82
– 68 – 8 |
Pentachloronitrobenzene |
I |
1.8 |
1.2 |
0.021 |
7.8 |
83
– 26 – 1 |
Pindone |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
83
– 79 – 4 |
Rotenone, commercial |
I |
18 |
12 |
0.21 |
78 |
84
– 66 – 2 |
Diethyl phthalate |
II |
25 |
17 |
0.30 |
108 |
84
– 74 – 2 |
Dibutyl phthalate |
II |
25 |
17 |
0.30 |
108 |
85
– 00
– 7 |
Diquat
dibromide, as the cation, inhalable fraction (see Diquat,
as the cation, inhalable fraction, CAS# 2764-72-9) |
|
|
|
|
|
85-00-7 |
Diquat
dibromide, as the cation, respirable
fraction (see Diquat, as the cation, respirable fraction, CAS# 2764-72-9) |
|
|
|
|
|
85
– 01 – 8 |
Phenanthrene as coal tar pitch volatile (see Coal tar pitch
volatiles, as benzene soluble aerosol, CAS# 65996-93-2) |
|
|
|
|
|
85
– 42 – 7 |
Hexahydrophthalic
anhydride, all isomers, inhalable fraction
and vapor |
II |
0.0025 |
0.0017 |
0.000030 |
0.011 |
85
– 44 – 9 |
Phthalic anhydride, inhalable fraction
and vapor |
I |
0.0071 |
0.0048 |
0.000085 |
0.031 |
86
– 50 – 0 |
Azinphos-methyl, inhalable fraction and vapor |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
86-74-8 |
Carbazole as coal tar pitch volatile (see Coal tar pitch volatiles,
as benzene soluble aerosol, CAS# 65996-93-2) |
|
|
|
|
|
86
– 88 – 4 |
ANTU |
I |
1.1 |
0.71 |
0.013 |
4.8 |
87
– 68 – 3 |
Hexachlorobutadiene |
I |
1.1 |
0.50 |
0.013 |
4.8 |
87
– 86 – 5 |
Pentachlorophenol, inhalable fraction
and vapor |
I |
1.8 |
1.2 |
0.021 |
7.8 |
88
– 06 – 2 |
2,4,6-Trichlorophenol |
I |
3.0 |
3.0 |
0.036 |
13 |
88
– 12 – 0 |
N-Vinyl-2-pyrrolidone |
II |
1.6 |
0.76 |
0.019 |
6.9 |
88
– 72 – 2 |
2-Nitrotoluene (see Nitrotoluene isomers, CAS# 1321-12-6) |
|
|
|
|
|
88
– 89 – 1 |
Picric acid |
II |
0.50 |
0.34 |
0.0059 |
2.2 |
89
– 72 – 5 |
o-sec-Butylphenol |
II |
218 |
104 |
2.6 |
945 |
90
– 04 – 0 |
o-Anisidine |
II |
2.5 |
1.7 |
0.030 |
11 |
90
– 12 – 0 |
1-Methyl naphthalene |
II |
15 |
9.7 |
0.18 |
65 |
91
– 08 – 7 |
2,6-Toluene diisocyanate, inhalable fraction and vapor (or as
TDI mixture) |
I |
0.025 |
0.017 |
0.00030 |
0.11 |
91
– 15 – 6 |
o-Phthalodinitrile, inhalable fraction
and vapor |
II |
7.0 |
3.4 |
0.084 |
31 |
91
– 20 – 3 |
Naphthalene |
I |
186 |
3.0 |
2.2 |
49 |
91
– 22 – 5 |
Quinoline |
I
|
0.0029 |
0.0029 |
0.000034 |
0.013 |
91
– 57 – 6 |
2-Methyl naphthalene |
II |
15 |
9.7 |
0.18 |
65 |
91
– 59 – 8 |
ß-Naphthlamamine |
I |
|
|
|
E |
91
– 94 – 1 |
3,3-Dichlorobenzidine |
I |
0.078 |
0.078 |
0.00093 |
0.34 |
92
– 52 – 4 |
Biphenyl |
I |
4.6 |
3.1 |
0.055 |
20 |
92
– 67 – 1 |
4-Aminodiphenyl |
I |
|
|
|
E |
92
– 84 – 2 |
Phenothiazine |
II |
35 |
17 |
0.42 |
152 |
92
– 87 – 5 |
Benzidine |
I |
0.029 |
0.019 |
0.00034 |
0.12 |
92
– 93 – 3 |
4-Nitrodiphenyl |
I |
|
|
|
E
|
93
– 76 – 5 |
2,4,5-T |
I |
36 |
24 |
0.43 |
156 |
94
– 36 – 0 |
Benzoyl peroxide |
II |
25 |
17 |
0.30 |
108 |
94
– 75 – 7 |
2,4-D, inhalable fraction |
I |
36 |
24 |
0.43 |
156 |
95
– 13 – 6 |
Indene |
III |
353 |
236 |
4.2 |
1531 |
95
– 47 – 6 |
o-Xylene |
I |
1550 |
100 |
18 |
1628 |
95
– 48
– 7 |
o-Cresol,
inhalable fraction and vapor (see Cresol, all
isomers, inhalable fraction and vapor, CAS# 1319-77-3) |
|
|
|
|
|
95
– 49 – 8 |
o-Chlorotoluene |
I |
925 |
617 |
11 |
4011 |
95
– 50 – 1 |
o-Dichlorobenzene |
I |
536 |
357 |
6.4 |
2324 |
95
– 53 – 4 |
o-Toluidine |
I |
31 |
21 |
0.37 |
134 |
95
– 54 – 5 |
o-Phenylenediamine |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
95
– 63 – 6 |
1,2,4-Trimethylbenzene (as Trimethylbenzene) |
II |
618 |
60 |
7.3 |
977 |
95-65-8 |
3,4-Dimethylphenol, inhalable fraction and vapor (see
Dimethylphenol, mixed isomers, inhalable fraction and vapor, CAS # 1300-71-6) |
|
|
|
|
|
95
– 80 – 7 |
Toluene-2,4-diamine |
I |
7.1 |
4.8 |
0.084 |
31 |
95-87-4 |
2,5-Dimethylphenol, inhalable fraction and vapor (see Dimethylphenol,
mixed isomers, inhalable fraction and vapor, CAS # 1300-71-6) |
|
|
|
|
|
96-05-9 |
Allyl methacrylate |
I |
26 |
12 |
0.31 |
112 |
96
– 12 – 8 |
1,2-Dibromo-3-chloropropane |
I |
0.20 |
0.20 |
0.0024 |
0.87 |
96
– 18 – 4 |
1,2,3-Trichloropropane |
I |
0.30 |
0.30 |
0.0036 |
1.3 |
96
– 22 – 0 |
Diethyl ketone |
II |
4965 |
2364 |
59 |
21531 |
96
– 33 – 3 |
Methyl acrylate |
II |
35 |
23 |
0.42 |
152 |
96
– 45 – 7 |
Ethylene thiourea |
I |
0.97 |
0.97 |
0.012 |
4.2 |
97
– 77 – 8 |
Disulfiram |
I |
7.1 |
4.8 |
0.084 |
31 |
98
– 00 – 0 |
Furfuryl alcohol |
II |
5.7 |
2.7 |
0.067 |
25 |
98
– 01 – 1 |
Furfural |
I |
2.8 |
1.9 |
0.033 |
12 |
98
– 07 – 7 |
Benzotrichloride |
I |
0.0030 |
0.0030 |
0.000036 |
0.013 |
98
– 51 – 1 |
p-tert-Butyl toluene |
II |
31 |
20 |
0.37 |
134 |
98
– 82 – 8 |
Cumene |
II |
1237 |
400 |
15 |
5364 |
98
– 83
– 9 |
alpha – Methyl
styrene |
I |
173 |
115 |
2.1 |
750 |
98
– 86 – 2 |
Acetophenone (including benzene from gasoline) |
II |
246 |
164 |
2.9 |
1067 |
98
– 88 – 4 |
Benzoyl chloride |
II |
14 |
9.4 |
0.17 |
61 |
98
– 95 – 3 |
Nitrobenzene |
I |
18 |
9.0 |
0.21 |
78 |
99
– 08 – 1 |
m-Nitrotoluene (see Nitrotoluene isomers, CAS# 1321-12-6) |
|
|
|
|
|
99
– 55 – 8 |
5-Nitro-o-toluidine,
inhalable fraction and vapor |
II |
5.0 |
3.4 |
0.060 |
22 |
99
– 65 – 0 |
1,3-Dinitrobenzene,
inhalable fraction and vapor |
I |
3.6 |
2.4 |
0.043 |
16 |
99
– 99 – 0 |
p-Nitrotoluene (see Nitrotoluene isomers, CAS# 1321-12-6) |
|
|
|
|
|
100
– 00 – 5 |
p-Nitrochlorobenzene |
I |
2.3 |
1.5 |
0.027 |
10 |
100
– 01 – 6 |
p-Nitroaniline |
I |
11 |
7.1 |
0.13 |
48 |
100
– 21 – 0 |
Terephthalic acid |
II |
50
|
34 |
0.59 |
217 |
100
– 25 – 4 |
1,4-Dinitrobenzene,
inhalable fraction and vapor (see Dinitrobenzene,
mixed isomers, inhalable fraction and vapor, CAS# 25154-54-5) |
|
|
|
|
|
100
– 37 – 8 |
2-Diethylaminoethanol |
II |
48 |
32 |
0.57 |
208 |
100
– 40 – 3 |
4-Vinyl cyclohexene |
II |
2.2 |
1.5 |
0.026 |
9.5 |
100
– 41 – 4 |
Ethyl benzene |
I |
1000 |
1000 |
12 |
4336 |
100
– 42 – 5 |
Styrene, monomer |
I |
1000 |
1000 |
12 |
4336 |
100
– 44 – 7 |
Benzyl chloride |
I |
19 |
12 |
0.23 |
82 |
100
– 61 – 8 |
N-methyl aniline |
III |
92 |
22 |
1.1 |
358 |
100
– 63 – 0 |
Phenylhydrazine |
II |
2.2 |
1.5 |
0.026 |
9.5 |
100
– 74 – 3 |
N-Ethylmorpholine |
II |
169 |
80 |
2.0 |
733 |
101
– 14 – 4 |
4,4-Methylene bis (2-chloroaniline), inhalable fraction and
vapor |
I |
0.39 |
0.26 |
0.0046 |
1.7 |
101
– 68 – 8 |
Methylene bisphenyl isocyanate |
I |
0.18 |
0.020 |
0.0021 |
0.33 |
101
– 77 – 9 |
4,4-Methylene dianiline |
II |
4.1 |
2.7 |
0.049 |
18 |
102
– 54 – 5 |
Dicyclopentadienyl
iron, as Fe |
II |
50 |
34 |
0.59 |
217 |
102
– 71 – 6 |
Triethanolamine |
II |
25 |
17 |
0.30 |
108 |
102
– 81 – 8 |
2-N-Dibutylaminoethanol |
II |
18 |
12 |
0.21 |
78 |
103-71-9 |
Phenyl isocyanate |
I |
0.087 |
0.058 |
0.0010 |
0.38 |
104
– 94 – 9 |
p-Anisidine |
II |
2.5 |
1.7 |
0.030 |
11 |
105
– 60 – 2 |
Caprolactam, inhalable fraction and vapor |
I |
18 |
12 |
0.21 |
78 |
105-67-9 |
2,4-Dimethylphenol, inhalable fraction and vapor (see
Dimethylphenol, mixed isomers, inhalable fraction and vapor, CAS# 1300-71-6) |
|
|
|
|
|
106
– 42 – 3 |
p-Xylene |
I |
1550 |
100 |
18 |
1628 |
106
– 44
– 5 |
p-Cresol,
inhalable fraction and vapor (see Cresol, all
isomers, inhalable fraction and vapor, CAS# 1319-77-3) |
|
|
|
|
|
106
– 46 – 7 |
p-Dichlorobenzene |
I |
800 |
800 |
9.5 |
3469 |
106
– 49 – 0 |
p-Toluidine |
II |
44 |
30 |
0.52 |
191 |
106
– 50 – 3 |
p-Phenylenediamine |
II |
0.50 |
0.34 |
0.0059 |
2.2 |
106
– 51 – 4 |
Quinone |
I |
1.6 |
1.0 |
0.019 |
6.9 |
106
– 87 – 6 |
Vinyl cyclohexene dioxide |
I |
2.0 |
1.4 |
0.024 |
8.7 |
106
– 88 – 7 |
1,2-Epoxybutane |
II |
20 |
20 |
0.24 |
87 |
106
– 89 – 8 |
Epichlorohydrin |
I |
6.8 |
1.0 |
0.081 |
16 |
106
– 92 – 3 |
Allyl glycidyl ether |
II |
23 |
16 |
0.27 |
100 |
106
– 93 – 4 |
Ethylene dibromide |
I |
0.050 |
0.050 |
0.00059 |
0.22 |
106
– 94 – 5 |
1-Bromopropane |
I |
1.8 |
1.2 |
0.021 |
7.8 |
106
– 95 – 6 |
Allyl
bromide |
I |
2.5 |
1.2 |
0.029 |
11 |
106-98-9 |
1-Butene
(see Butenes, all isomers, CAS# 25167-67-3) |
|
|
|
|
|
106
– 99 – 0 |
1,3-Butadiene |
I |
2.0 |
2.0 |
0.024 |
8.7 |
107-01-7 |
2-Butene (see Butenes, all isomers,
CAS# 25167-67-3) |
|
|
|
|
|
107
– 02 – 8 |
Acrolein |
I |
0.82 |
0.020 |
0.0097 |
0.33 |
107
– 05 – 1 |
Allyl chloride |
I |
11 |
1.0 |
0.13 |
16 |
107
– 06 – 2 |
Ethylene dichloride |
I |
143 |
95 |
1.7 |
620 |
107
– 07 – 3 |
Ethylene chlorohydrin |
I |
12 |
7.9 |
0.14 |
52 |
107
– 13 – 1 |
Acrylonitrile |
I |
15 |
2.0 |
0.18 |
33 |
107
– 15 – 3 |
Ethylenediamine |
II |
176 |
84 |
2.1 |
763 |
107
– 18 – 6 |
Allyl alcohol |
I |
4.3 |
2.9 |
0.051 |
19 |
107
– 19 – 7 |
Propargyl alcohol |
I |
8.2 |
5.5 |
0.097 |
36 |
107
– 20 – 0 |
Chloroacetaldehyde |
II |
16 |
11 |
0.19 |
69 |
107
– 21 – 1 |
Ethylene
glycol, vapor fraction |
II |
319 |
213 |
3.8 |
1384 |
107
– 22 – 2 |
Glyoxal, inhalable fraction and vapor |
II |
0.70 |
0.34 |
0.0083 |
3.0 |
107
– 30 – 2 |
Chloromethyl methyl ether |
I |
|
|
|
E |
107-31-3 |
Methyl formate |
III |
2558 |
1218 |
30 |
11094 |
107-41-5 |
Hexylene glycol, vapor fraction |
II |
851 |
405 |
10 |
3690 |
107
– 49 – 3 |
Tetraethyl pyrophosphate (TEPP), inhalable fraction and vapor |
I |
0.036 |
0.024 |
0.00043 |
0.16 |
107
– 98 – 2 |
1-Methoxy-2-propanol |
II |
2000 |
2000 |
24 |
8673 |
108
– 03 – 2 |
1-Nitropropane |
II |
458 |
305 |
5.4 |
1986 |
108
– 05 – 4 |
Vinyl acetate |
I |
200 |
200 |
2.4 |
867 |
108 –
08 –
7 |
2,4-Dimethylpentane (see Heptane, all isomers, CAS# 142-82-5) |
|
|
|
|
|
108
– 10 – 1 |
Methyl isobutyl ketone (MIBK) |
I |
3000 |
3000 |
36 |
13009 |
108
– 18 – 9 |
Diisopropylamine |
II |
148 |
70 |
1.8 |
642 |
108-21-4 |
Isopropyl acetate (see n-Propyl acetate, CAS# 109-60-4) |
|
|
|
|
|
108
– 24 – 7 |
Acetic
anhydride |
I |
21 |
10 |
0.25 |
91 |
108
– 31 – 6 |
Maleic
anhydride, inhalable fraction and vapor |
II |
0.050 |
0.034 |
0.00059 |
0.22 |
108
– 38 – 3 |
m-Xylene |
I |
1550 |
100 |
18 |
1628 |
108
– 39
– 4 |
m-Cresol,
inhalable fraction and vapor (see Cresol, all isomers,
inhalable fraction and vapor, CAS# 1319-77-3) |
|
|
|
|
|
108
– 44 – 1 |
m-Toluidine |
II |
44 |
30 |
0.52 |
191 |
108
– 45 – 2 |
m-Phenylenediamine |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
108
– 46 – 3 |
Resorcinol |
II |
226 |
151 |
2.7 |
980 |
108
– 67 – 8 |
1,3,5-Trimethylbenzene (as Trimethylbenzene) |
II |
618 |
60 |
7.3 |
977 |
108-68-9 |
3,5-Dimethylphenol, inhalable fraction and vapor (see
Dimethylphenol, mixed isomers, inhalable fraction and vapor, CAS# 1300-71-6) |
|
|
|
|
|
108 – 88 – 3 |
Toluene |
I |
5000 |
5000 |
59 |
21682 |
108
– 90 – 7 |
Chlorobenzene |
II |
231 |
154 |
2.7 |
1002 |
108
– 91 – 8 |
Cyclohexylamine |
I |
146 |
98 |
1.7 |
633 |
108
– 93 – 0 |
Cyclohexanol |
I |
736 |
490 |
8.7 |
3192 |
108
– 94 – 1 |
Cyclohexanone |
II |
404 |
269 |
4.8 |
1752 |
108
– 95 – 2 |
Phenol |
I |
68 |
45 |
0.81 |
295 |
108
– 98 – 5 |
Phenyl mercaptan |
I |
1.6 |
1.1 |
0.019 |
6.9 |
109
– 59 – 1 |
2-Isopropoxyethanol |
II |
746 |
355 |
8.9 |
3235 |
109-60-4 |
n-Propyl acetate |
III |
8702 |
4144 |
103 |
37737 |
109-63-7 |
Boron triflouride diethyl ether, as BF3 |
III |
12 |
5.8 |
0.14 |
52 |
109
– 73 – 9 |
n-Butylamine |
II |
75 |
50 |
0.89 |
325 |
109
– 79 – 5 |
n‑Butyl mercaptan |
I |
9.0 |
4.3 |
0.11 |
39 |
109
– 86 – 4 |
2-Methoxyethanol (EGME) |
I |
20 |
20 |
0.24 |
87 |
109
– 87 – 5 |
Methylal |
II |
15644 |
10429 |
186 |
67840 |
109
– 89 – 7 |
Diethylamine |
II |
75 |
50 |
0.89 |
325 |
109
– 90 – 0 |
Ethyl isocyanate |
I |
0.29 |
0.14 |
0.0030 |
1.3 |
109
– 99 – 9 |
Tetrahydrofuran |
II |
2000 |
2000 |
24 |
8673 |
110 – 49 – 6 |
2-Methoxyethyl
acetate (EGMEA) |
I |
1.7 |
1.2 |
0.020 |
7.4 |
110 – 54 – 3 |
n-Hexane |
II |
885 |
700 |
11 |
3838 |
110
– 62 – 3 |
n-Valeraldehyde |
II |
1239 |
590 |
15 |
5373 |
110
– 80 – 5 |
2-Ethoxyethanol (EGEE) |
I |
200 |
200 |
2.4 |
867 |
110
– 82 – 7 |
Cyclohexane |
II |
6000 |
6000 |
71 |
26019 |
110
– 83 – 8 |
Cyclohexene |
II |
5080 |
3387 |
60 |
22029 |
110
– 85 – 0 |
Piperazine
and salts (as piperazine), inhalable fraction and vapor |
I |
0.50 |
0.24 |
0.0059 |
2.2 |
110
– 86 – 1 |
Pyridine |
II |
16 |
11 |
0.19 |
69 |
110
– 91 – 8 |
Morpholine |
II |
357 |
238 |
4.2 |
1548 |
111
– 15 – 9 |
2-Ethoxyethyl acetate (EGEEA) |
I |
96 |
64 |
1.1 |
416 |
111
– 30 – 8 |
Glutaraldehyde, activated or unactivated |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
111
– 40 – 0 |
Diethylene triamine |
I |
21 |
10 |
0.25 |
91 |
111
– 42 – 2 |
Diethanolamine,
inhalable fraction and vapor |
I |
3.6 |
2.4 |
0.042 |
15 |
111
– 44 – 4 |
Dichloroethyl ether |
I |
104 |
69 |
1.2 |
451 |
111
– 65 – 9 |
Octane, all isomers |
I |
7000 |
3333 |
83 |
30355 |
111
– 69 – 3 |
Adiponitrile |
I |
44 |
21 |
0.52 |
191 |
111
– 76 – 2 |
2-Butoxyethanol |
I |
1600 |
1600 |
19 |
6938 |
112
– 07 – 2 |
2-Butoxyethyl acetate |
II |
659 |
439 |
7.8 |
2858 |
112-34-5 |
Diethylene glycol monobutyl ether
(DGME), inhalable fraction and vapor |
III |
1382 |
658 |
16 |
5994 |
112
– 55 – 0 |
Dodecyl mercaptan |
I |
3.0 |
2.0 |
0.036 |
13 |
114
– 26 – 1 |
Propoxur, inhalable fraction and vapor |
I |
1.8 |
1.2 |
0.021 |
7.7 |
115
– 11 – 7 |
Isobutene |
II |
2886 |
1924 |
34 |
12515 |
115
– 29 – 7 |
Endosulfan,
inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
115
– 77 – 5 |
Pentaerythritol |
II |
50 |
34 |
0.59 |
217 |
115
– 90 – 2 |
Fensulfothion, inhalable fraction and vapor |
I |
0.036 |
0.024 |
0.00043 |
0.16 |
116-06-3 |
Aldicarb, inhalable fraction and vapor |
I |
0.018 |
0.012 |
0.00021 |
0.077 |
116
– 14 – 3 |
Tetrafluoroethylene |
III |
171 |
81 |
2.0 |
742 |
116
– 15 – 4 |
Hexafluoropropylene |
II |
4.3 |
2.1 |
0.051 |
19 |
117
– 81 – 7 |
Di(2-ethyl
hexyl)phthalate |
I |
18 |
12 |
0.21 |
78 |
118
– 52 – 5 |
1,3-Dichloro-5,5-dimethyl hydantoin |
II |
1.4 |
0.67 |
0.017 |
6.1 |
118
– 74 – 1 |
Hexachlorobenzene |
I |
0.0070 |
0.0050 |
0.000083 |
0.030 |
118
– 96 – 7 |
2,4,6-Trinitrotoluene, inhalable fraction
and vapor |
II |
0.50 |
0.34 |
0.0059 |
2.2 |
119
– 93 – 7 |
o-Tolidine |
I |
0.071 |
0.048 |
0.00084 |
0.31 |
120-12-7 |
Anthracene as coal tar pitch volatiles (see coal tar pitch
volatiles as benzene soluble aerosol, CAS# 65996-93-2) |
|
|
|
|
|
120
– 80 – 9 |
Catechol |
II |
116 |
77 |
1.4 |
503 |
120
– 82 – 1 |
1,2,4-Trichlorobenzene |
II |
186 |
124 |
2.2 |
807 |
121
– 14 – 2 |
2,4-Dinitrotoluene (see Dinitrotoluene,
mixed isomers, CAS# 25321-14-6) |
|
|
|
|
|
121
– 44 – 8 |
Triethylamine |
II |
10 |
7.0 |
0.12 |
45 |
121
– 45 – 9 |
Trimethyl phosphite |
I |
50 |
24 |
0.59 |
217 |
121
– 69 – 7 |
Dimethylaniline |
II |
126 |
84 |
1.5 |
546 |
121
– 75 – 5 |
Malathion, inhalable fraction and vapor |
I |
3.6 |
2.4 |
0.043 |
16 |
121
– 82 – 4 |
Cyclonite |
I |
1.8 |
1.2 |
0.021 |
7.8 |
122-34-9 |
Simazine, inhalable fraction |
I |
1.8 |
1.2 |
0.021 |
7.7 |
122
– 39 – 4 |
Diphenylamine |
II |
50 |
34 |
0.59 |
217 |
122
– 60 – 1 |
Phenyl glycidyl ether (PGE) |
I |
2.1 |
1.4 |
0.025 |
9.1 |
122
– 66 – 7 |
1,2-Diphenylhydrazine |
I |
0.050 |
0.050 |
0.00059 |
0.22 |
123
– 31 – 9 |
Hydroquinone |
I |
3.6 |
2.4 |
0.043 |
16 |
123
– 38 – 6 |
Propionaldehyde |
II |
239 |
8.0 |
2.8 |
130 |
123-39-7 |
Monomethylformamide |
I |
8.6 |
5.8 |
0.10 |
37 |
123
– 42 – 2 |
Diacetone alcohol |
II |
1197 |
798 |
14 |
5191 |
123
– 51 – 3 |
Isoamyl alcohol |
II |
1816 |
1211 |
22 |
7875 |
123
– 54 – 6 |
2,4-Pentanedione |
I |
366 |
244 |
4.3 |
1587 |
123
– 86 – 4 |
n-Butyl acetate |
II |
1673 |
797 |
20 |
7254 |
123
– 91 – 1 |
1,4-Dioxane |
I |
258 |
30 |
3.1 |
488 |
124
– 09 – 4 |
1,6-Hexanediamine |
II |
12 |
7.7 |
0.14 |
52 |
124
– 40 – 3 |
Dimethylamine |
II |
65 |
31 |
0.77 |
282 |
124
– 64 – 1 |
Tetrakis (hydroxymethyl) phosphonium chloride |
II |
10 |
6.7 |
0.12 |
43 |
126
– 73 – 8 |
Tributyl phosphate, inhalable fraction
and vapor |
II |
25 |
17 |
0.30 |
108 |
126
– 98 – 7 |
Methylacrylonitrile |
I |
9.6 |
6.4 |
0.11 |
42 |
126
– 99
– 8 |
β-Chloroprene |
I |
13 |
8.6 |
0.15 |
56 |
127
– 00 – 4 |
1-Chloro-2-propanol |
II |
28 |
13 |
0.33 |
121 |
127
– 18 – 4 |
Perchloroethylene |
I |
607 |
40 |
7.2 |
651 |
127
– 19 – 5 |
N,N-Dimethylacetamide |
I |
127 |
85 |
1.5 |
552 |
127
– 91 – 3 |
ß-Pinene (see Turpentine and select monoterpenes, CAS#
8006-64-2) |
|
|
|
|
|
128
– 37 – 0 |
Butylated hydroxytoluene (BHT), inhalable fraction and vapor |
II |
10 |
6.7 |
0.12 |
43 |
129
– 00 – 0 |
Pyrene as coal tar pitch volatiles (see Coal tar pitch
volatiles, as benzene soluble aerosol, CAS# 65996-93-2) |
|
|
|
|
|
131
– 11 – 3 |
Dimethylphthalate |
II |
25 |
17 |
0.30 |
108 |
133
– 06 – 2 |
Captan,
inhalable fraction |
I |
18 |
12 |
0.21 |
78 |
133-07-3 |
Folpet,
inhalable fraction |
I |
5.0 |
2.4 |
0.059 |
22 |
135
– 88 – 6 |
N-Phenyl-ß-naphthylamine |
I |
|
|
|
E |
136
– 78 – 7 |
Sesone |
II |
50 |
34 |
0.59 |
217 |
137
– 05 – 3 |
Methyl 2-cyanoacrylate |
I |
3.3 |
2.2 |
0.039 |
14 |
137
– 26 – 8 |
Thiram, inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
140
– 11 – 4 |
Benzyl acetate |
II |
307 |
205 |
3.6 |
1331 |
140
– 88 – 5 |
Ethyl acrylate |
I |
71 |
48 |
0.84 |
308 |
141
– 32 – 2 |
n-Butyl acrylate |
I |
52 |
25 |
0.62 |
225 |
141
– 43 – 5 |
Ethanolamine |
I |
27 |
18 |
0.32 |
117 |
141
– 66 – 2 |
Dicrotophos, inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
141
– 78 – 6 |
Ethyl acetate |
II |
10141 |
4829 |
120 |
43976 |
141
– 79 – 7 |
Mesityl oxide |
II |
302 |
201 |
3.6 |
1310 |
142
– 82 – 5 |
Heptane, all isomers |
II |
8249 |
5500 |
98 |
35771 |
143
– 33 – 9 |
Sodium
cyanide, as CN (see Hydrogen cyanide and cyanide salts, as CN, CAS# 74-90-8) |
|
|
|
|
|
144
– 62 – 7 |
Oxalic acid, anhydrous |
I |
3.6 |
2.4 |
0.042 |
15 |
148
– 01 – 6 |
3,5-Dinitro-o-tolumide |
II |
7.0 |
3.4 |
0.084 |
31 |
149
– 57 – 5 |
2-Ethylhexanoic acid, inhalable fraction and vapor |
I |
18 |
12 |
0.21 |
78 |
151
– 50 – 8 |
Potassium
cyanide, as CN (see Hydrogen cyanide and cyanide salts, as CN, CAS# 74-90-8) |
|
|
|
|
|
151
– 56 – 4 |
Ethylenimine |
I |
0.31 |
0.21 |
0.0037 |
1.4 |
151
– 67 – 7 |
Halothane |
I |
2020 |
962 |
24 |
8760 |
156
– 59 – 2 |
cis
1,2-Dichloroethylene |
II |
3989 |
2659 |
47 |
17298 |
156
– 60 – 5 |
trans-1,2-Dichloroethylene |
II |
3989 |
2659 |
47 |
17298 |
156
– 62 – 7 |
Calcium cyanamide |
II |
2.5 |
1.7 |
0.030 |
11 |
205
– 99 – 2 |
Benzo[b]fluoranthene |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
218
– 01 – 9 |
Chrysene |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
260-94-6 |
Acridine, as coal tar pitch volatiles (see Coal tar pitch
volatiles, as benzene soluble aerosol, CAS# 65996-93-2) |
|
|
|
|
|
298
– 00 – 0 |
Methyl
parathion, inhalable fraction and vapor |
I |
0.071 |
0.048 |
0.00084 |
0.31 |
298
– 02 – 2 |
Phorate, inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
298
– 04 – 4 |
Disulfoton,
inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
299 – 84 – 3 |
Ronnel – inhalable fraction and vapor |
I |
18 |
12 |
0.21 |
78 |
299
– 86 – 5 |
Crufomate |
I |
18 |
12 |
0.21 |
78 |
300
– 76 – 5 |
Naled,
inhalable fraction and vapor |
II |
0.50 |
0.34 |
0.0059 |
2.2 |
302
– 01 – 2 |
Hydrazine |
I |
0.046 |
0.031 |
0.00055 |
0.20 |
309
– 00 – 2 |
Aldrin,
inhalable fraction and
vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
314
– 40 – 9 |
Bromacil |
I |
36 |
24 |
0.43 |
156 |
330
– 54 – 1 |
Diuron |
I |
36 |
24 |
0.43 |
156 |
333
– 41 – 5 |
Diazinon, inhalable fraction and vapor |
I |
0.036 |
0.024 |
0.00043 |
0.16 |
334
– 88 – 3 |
Diazomethane |
I |
1.2 |
0.81 |
0.014 |
5.2 |
353-42-4 |
Boron
triflouride dimethyl ether, as BF3 |
III |
9.7 |
4.6 |
0.12 |
42 |
353
– 50 – 4 |
Carbonyl
fluoride |
I |
27 |
13 |
0.32 |
117 |
382
– 21 – 8 |
Perfluoroisobutylene |
I |
0.29 |
0.20 |
0.0034 |
1.3 |
409
– 21 – 2 |
Silicon
carbide: non-fibrous (inhalable fraction) |
II |
50 |
34 |
0.59 |
217 |
409
– 21 – 2 |
Silicon
carbide: non-fibrous (respirable fraction) |
II |
15 |
10 |
0.18 |
65 |
420
– 04 – 2 |
Cyanamide |
II |
14 |
6.7 |
0.17 |
61 |
431
– 03 – 8 |
Diacetyl |
II |
0.25 |
0.12 |
0.0029 |
1.1 |
460
– 19 – 5 |
Cyanogen |
II
|
54 |
0.80 |
0.64 |
13 |
463
– 51 – 4 |
Ketene |
I |
3.1 |
2.0 |
0.037 |
13 |
463
– 58 – 1 |
Carbonyl
sulfide |
II |
87 |
41 |
1.0 |
377 |
479
– 45 – 8 |
Tetryl |
II |
7.5 |
5.0 |
0.089 |
33 |
504
– 29 – 0 |
2-Aminopyridine |
I |
6.8 |
4.5 |
0.081 |
29 |
506
– 64 – 9 |
Silver
cyanide (as hydrogen cyanide) |
I |
18 |
12 |
0.21 |
78 |
506-68-3 |
Cyanogen
bromide |
I |
4.6 |
3.1 |
0.055 |
20 |
506
– 77 – 4 |
Cyanogen
chloride |
I |
2.7 |
1.8 |
0.032 |
12 |
509
– 14 – 8 |
Tetranitromethane |
I |
0.14 |
0.095 |
0.0017 |
0.61 |
513-79-1 |
Cobaltous
carbonate, as Co, inhalable fraction (see Cobalt and inorganic compounds, as
Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
526-73-8 |
1,2,3-Trimethylbenzene,
–(as trimethylbenzene) |
II |
618 |
60 |
7.3 |
977 |
526-75-0 |
2,3-Dimethylphenol,
inhalable fraction and vapor (see Dimethylphenol, mixed isomers, inhalable
fraction and vapor, CAS# 1300-71-6) |
|
|
|
|
|
528
– 29 – 0 |
1,2-Dinitrobenzene,
inhalable fraction and vapor (see Dinitrobenzene,
mixed isomers, inhalable fraction and vapor, CAS# 25154-54-5) |
|
|
|
|
|
532
– 27 – 4 |
2-Chloroacetophenone |
I |
1.1 |
0.030 |
0.013 |
0.49 |
534
– 52 – 1 |
4,6-Dinitro-o-cresol,
inhalable fraction and vapor |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
540
– 59 – 0 |
1,2-Dichloroethylene,
all isomers |
III |
16521 |
7867 |
196 |
71643 |
542
– 56 – 3 |
Isobutyl
nitrite |
II |
24 |
14 |
0.29 |
104 |
542
– 75 – 6 |
1,3-Dichloropropene |
I |
20 |
20 |
0.24 |
87 |
542
– 88 – 1 |
bis(Chloromethyl)
ether |
I |
0.017 |
0.011 |
0.00020 |
0.074 |
542
– 92 – 7 |
Cyclopentadiene
(see Dicyclopentadiene, CAS# 77-73-6) |
|
|
|
|
|
543-80-6 |
Barium
acetate, as Ba (see Barium and soluble compounds, as Ba, CAS# 7440-39-3) |
|
|
|
|
|
552
– 30 – 7 |
Trimetallic
anhydride, inhalable fraction and vapor |
II |
0.0025 |
0.0017 |
0.000030 |
0.011 |
556
– 52 – 5 |
Glycidol |
I |
30 |
15 |
0.36 |
130 |
557
– 05 – 1 |
Zinc
stearate, inhalable fraction (see Stearates, inhalable fraction, CAS# 0-00-0) |
|
|
|
|
|
557-05-1 |
Zinc
stearate, respirable fraction (see Stearates, respirable fraction, CAS#
0-00-0) |
|
|
|
|
|
558
– 13 – 4 |
Carbon tetrabromide |
III |
21 |
14 |
0.25 |
91 |
563
– 12 – 2 |
Ethion, inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
563
– 80 – 4 |
Methyl
isopropyl ketone |
I |
352 |
168 |
4.2 |
1526 |
565
– 59 – 3 |
2,3-Dimethylpentane |
|
|
|
|
|
576-26-1 |
2,6-Dimethylphenol,
inhalable fraction and vapor (see Dimethylphenol, mixed isomers, inhalable
fraction and vapor, CAS# 1300-71-6) |
|
|
|
|
|
584
– 84 – 9 |
Toluene-2,4-diisocyanate, inhalable fraction and vapor (or as
TDI mixture) |
I |
0.025 |
0.017 |
0.00030 |
0.11 |
589
– 34 – 4 |
3-Methylhexane
(see Heptane, all isomers, CAS# 142-82-5) |
|
|
|
|
|
590-18-1 |
Cis-2-Butene
(see Butenes, all isomers, CAS# 25167-67-3) |
|
|
|
|
|
590
– 35 – 2 |
2,2-Dimethylpentane |
|
|
|
|
|
591
– 76 – 4 |
2-Methylhexane
|
|
|
|
|
|
591
– 78 – 6 |
Methyl-n-butyl
ketone |
II |
101 |
30 |
1.2 |
438 |
592
– 01 – 8 |
Calcium cyanide as CN (see Hydrogen cyanide and cyanide salts,
as CN, CAS# 74-90-8) |
|
|
|
|
|
593
– 60 – 2 |
Vinyl
bromide |
I |
7.9 |
5.2 |
0.093 |
34 |
594
– 42 – 3 |
Perchloromethyl
mercaptan |
I |
2.7
|
1.8 |
0.032 |
12 |
594
– 72 – 9 |
1,1-Dichloro-1-nitroethane |
II |
85 |
40 |
1.0 |
369 |
598
– 78 – 7 |
2-Chloropropionic
acid |
I |
2.2 |
1.0 |
0.026 |
9.5 |
600
– 25 – 9 |
1-Chloro-1-nitropropane |
II |
70 |
34 |
0.83 |
304 |
602-01-7 |
2,3-Dinitrotoluene |
II |
1.4 |
0.67 |
0.017 |
6.1 |
606-20-2 |
2,6-Dinitrotoluene
(see 2,3-Dinitrotoluene, CAS# 602-01-7) |
|
|
|
|
|
610-39-9 |
3,4-Dinitrotoluene
(see 2.3-Dinitrotoluene, CAS# 602-01-7) |
|
|
|
|
|
618-85-9 |
3,5-Dinitrotoluene
(see 2.3-Dinitrotoluene, CAS# 602-01-7) |
|
|
|
|
|
619-15-8 |
2,5-Dinitrotoluene
(see 2.3-Dinitrotoluene, CAS# 602-01-7) |
|
|
|
|
|
624-64-6 |
Trans-2-Butene
(see Butenes, all isomers, CAS# 25167-67-3) |
|
|
|
|
|
624
– 83 – 9 |
Methyl
isocyanate |
I |
0.17 |
0.11 |
0.0020 |
0.73 |
624
– 92 – 0 |
Dimethyl
disulfide |
II |
9.7 |
6.5 |
0.12 |
42 |
626
– 17 – 5 |
m-Phthalodinitrile, inhalable fraction and vapor |
II |
25 |
17 |
0.30 |
108 |
628
– 96 – 6 |
Ethylene
glycol dinitrate |
II |
4.4 |
1.0 |
0.052 |
16 |
637
– 92 – 3 |
Ethyl
tert-butyl ether (ETBE) |
II |
736 |
350 |
8.7 |
3192 |
638
– 21 – 1 |
Phenylphosphine |
I |
0.82 |
0.55 |
0.0097 |
3.6 |
643-79-8 |
o-Phthalaldehyde, vapor fraction |
II |
0.0028 |
0.0018 |
0.000033 |
0.012 |
646
– 06 – 0 |
1,3-Dioxolane |
II |
427 |
203 |
5.1 |
1852 |
681
– 84 – 5 |
Methyl silicate |
I |
21 |
14 |
0.25 |
91 |
684
– 16 – 2 |
Hexafluoroacetone |
I |
2.4 |
1.6 |
0.029 |
10 |
688
– 73 – 3 |
tri-N-Butylstannane hydride as Sn (see
Tin, organic compounds, as SN, CAS# 7440-31-5) |
|
|
|
|
|
764
– 41 – 0 |
1,4-Dichloro-2-butene |
I |
0.089 |
0.060 |
0.0011 |
0.39 |
768
– 52 – 5 |
N-Isopropylaniline |
II |
77 |
37 |
0.91 |
334 |
822
– 06 – 0 |
Hexamethylene
diisocyanate |
I |
0.12 |
0.010 |
0.0014 |
0.16 |
872
– 50 – 4 |
n-Methyl-2-pyrrolidone |
I |
1429 |
952 |
17 |
6197 |
919
– 86 – 8 |
Demeton-S-methyl,
inhalable fraction and
vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
944 – 22 – 9 |
Fonofos – inhalable
fraction and vapor |
I |
0.036 |
0.024 |
0.00043 |
0.16 |
994
– 05 – 8 |
tert-Amyl
methyl ether (TAME) |
II |
421 |
280 |
5.0 |
1826 |
999
– 61 – 1 |
2-Hydroxypropyl
acrylate |
I |
14 |
6.7 |
0.17 |
61 |
1024
– 57 – 3 |
Heptachlor
epoxide |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
1120
– 71 – 4 |
Propane
sultone |
I |
|
|
|
E |
1189-85-1 |
Tert-Butyl
chromate, as CrO3 |
II |
0.50 |
0.34 |
0.0060 |
2.2 |
1213-99-1 |
Nickel
(II) oxide, as Ni, inhalable fraction, (see Nickel, insoluble inorganic
compounds as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
1300-71-6 |
Dimethylphenol,
mixed isomers, inhalable fraction and vapor |
II |
25 |
17 |
0.30 |
109 |
1300
– 73 – 8 |
Xylidine
(mixed isomers), inhalable fraction and vapor |
II |
13 |
8.4 |
0.15 |
56 |
1303
– 00 – 0 |
Gallium
arsenide, respirable fraction |
I |
0.0011 |
0.00071 |
0.000013 |
0.0046 |
1303
– 96 – 4 |
Borax,
inhalable fraction (see Borate compounds, inorganic, inhalable fraction, CAS#
0-00-0) |
|
|
|
|
|
1304
– 28 – 5 |
Barium
oxide as Ba, (see |
|
|
|
|
|
1304
– 56 – 9 |
Beryllium
oxide as Be, inhalable fraction (see Beryllium and compounds, as Be,
inhalable fraction, CAS# 7440-41-7) |
|
|
|
|
|
1304
– 82 – 1 |
Bismuth
telluride Se-doped, as Bi2Te3 |
II |
25 |
17 |
0.30 |
108 |
1305
– 62 – 0 |
Calcium hydroxide |
III |
104 |
50 |
1.2 |
451 |
1306
– 19 – 0 |
Cadmium oxide as Cd, respirable fraction (see Cadmium and
compounds, as Cd, respirable fraction, CAS# 7440-43-9) |
|
|
|
|
|
1306-23-6 |
Cadmium sulfide, as Cd, respirable fraction (see Cadmium and
compounds, as Cd, respirable fraction, CAS# 7440-43-9) |
|
|
|
|
|
1306-23-6 |
Cadmium sulfide, as Cd, total particulate (see Cadmium and
compounds, as Cd, total particulate, CAS# 7440-43-9) |
|
|
|
|
|
1307-96-6 |
Cobaltous oxide, as Co, inhalable fraction (see Cobalt and
inorganic compounds, as Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
1308-06-1 |
Cobalt oxide, as Co, inhalable fraction (see Cobalt and
inorganic compounds, as Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
1308-31-2 |
Chromite, as Cr(III), inhalable fraction (see Trivalent chromium
compounds, as Cr (III), inhalable fraction, CAS# 16065-83-1) |
|
|
|
|
|
1308-38-9 |
Chromium oxide, as Cr (III), inhalable fraction (see Trivalent
chromium compounds, as Cr (III), inhalable fraction, CAS# 16065-83-1) |
|
|
|
|
|
1309
– 37 – 1 |
Iron oxide (Fe2O3)
– respirable fraction |
II |
25 |
17 |
0.30 |
108 |
1309
– 64 – 4 |
Antimony trioxide |
I |
1.8 |
0.20 |
0.021 |
3.3 |
1310
– 58 – 3 |
Potassium hydroxide |
II |
11 |
6.7 |
0.13 |
48 |
1313
– 13 – 9 |
Manganese
dioxide as Mn, respirable fraction |
II |
1.0 |
0.67 |
0.012 |
4.3 |
1313-13-9 |
Manganese
(IV) dioxide as Mn, inhalable fraction (see Manganese, elemental an inorganic compounds as Mn, inhalable fraction, CAS#
7439-96-5) |
|
|
|
|
|
1313-99-1 |
Nickel
(II) oxide, as Ni, inhalable fraction (see Nickel, soluble inorganic
compounds, as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
1314-04-1 |
Nickel
sulfide, as Ni, inhalable fraction (see Nickel, insoluble inorganic
compounds, as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
1314
– 06 – 3 |
Nickel
peroxide, as Ni, inhalable fraction
(see Nickel soluble inorganic compounds, as Ni, inhalable fraction, CAS#
7440-02-0) |
|
|
|
|
|
1314
– 13 – 2 |
Zinc
oxide, respirable fraction |
II |
10 |
6.7 |
0.12 |
44 |
1314-35-8 |
Tungsten
trioxide, as W, respirable fraction (see Tungsten and compounds, in absence
of cobalt, as W, respirable fraction, CAS# 7440-33-7) |
|
|
|
|
|
1314
– 62 – 1 |
Vanadium
pentoxide as Va, inhalable fraction |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
1314
– 80 – 3 |
Phosphorus
pentasulfide |
II |
5.0 |
3.4 |
0.059 |
22 |
1317-34-6 |
Manganese
(III) oxide, as Mn, respirable fraction (see Manganese elemental and
inorganic compounds, as Mn, respirable fraction, CAS# 7439-96-5) |
|
|
|
|
|
1317-34-6 |
Manganese
(III) oxide, as Mn, inhalable fraction (see Manganese elemental and inorganic
compounds, as Mn, inhalable fraction, CAS# 7439-96-5) |
|
|
|
|
|
1317
– 36 – 8 |
Lead
monoxide, as Pb (see Lead, and inorganic compounds, as Pb, CAS# 7439-92-1) |
|
|
|
|
|
1317
– 39 – 1 |
Copper
(I) oxide, as Cu (see Copper, dusts and mists, as
Cu, CAS# 7440-50-8) |
|
|
|
|
|
1317
– 95 – 9 |
Silica,
Crystalline – Tripoli, respirable fraction |
I |
0.089 |
0.060 |
0.0011 |
0.39 |
1319
– 77
– 3 |
Cresol, all
isomers, inhalable fraction and vapor |
I |
71 |
48 |
0.84 |
308 |
1321-12-6 |
Nitrotoluene
isomers |
I |
39 |
26 |
0.46 |
169 |
1321
– 64 – 8 |
Pentachloronaphthalene,
inhalable fraction and vapor |
II |
2.5 |
1.7 |
0.030 |
11 |
1321
– 65 – 9 |
Trichloronaphthalene |
II |
25 |
17 |
0.30 |
108 |
1330
– 20 – 7 |
Xylene |
I |
1550 |
100 |
18 |
1628 |
1330
– 43 – 4 |
Sodium
tetraborate, inhalable fraction (see Borate compounds, inorganic,
inhalable fraction, CAS# 0-00-0) |
|
|
|
|
|
1332
– 58 – 7 |
Kaolin,
containing no asbestos, respirable fraction |
II |
10 |
6.7 |
0.12 |
43 |
1333
– 82 – 0 |
Chromium, trioxide, as Cr (VI), inhalable fraction (see
Hexavalent chromium compounds, as Cr (VI), inhalable fraction, CAS#
18540-29-9) |
|
|
|
|
|
1333-86-4 |
Carbon black, inhalable fraction |
II |
15 |
10 |
0.18 |
65 |
1335
– 87 – 1 |
Hexachloronaphthalene |
III |
3.0 |
2.0 |
0.036 |
13 |
1335
– 88 – 2 |
Tetrachloronaphthalene |
II |
10 |
6.7 |
0.12 |
43 |
1336
– 36 – 3 |
Polychlorinated biphenyls (Aroclors) |
I |
0.10 |
0.10 |
0.0012 |
0.43 |
1338
– 23 – 4 |
Methyl ethyl ketone peroxide |
I |
5.4 |
3.6 |
0.064 |
23 |
1395
– 21 – 7 |
Subtilisins
as crystalline active enzyme |
II |
0.00030 |
0.00020 |
0.0000036 |
0.0013 |
1563
– 66 – 2 |
Carbofuran,
inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
1582
– 09 – 8 |
Trifluraline |
I |
4.6 |
4.6 |
0.055 |
20 |
1634
– 04 – 4 |
Methyl-tert butyl ether |
II |
3000 |
3000 |
36 |
13009 |
1746 – 01 – 6 |
2,3,7,8-Tetrachlorodibenzeno-p-Dioxin |
I |
2.3E-7 |
2.3E-7 |
2.7E-9 |
1.0E-6 |
1910-42-5 |
Paraquat
dichloride, as the cation, inhalable fraction (see Paraquat as the cation,
inhalable fraction, CAS# 4685-14-7) |
|
|
|
|
|
1912
– 24 – 9 |
Atrazine
(and related symmetrical triazines), inhalable fraction |
I |
7.1 |
4.8 |
0.085 |
31 |
1918
– 02 – 1 |
Picloram |
II |
50 |
34 |
0.59 |
217 |
1929
– 82 – 4 |
Nitrapyrin,
inhalable fraction and vapor |
I |
50 |
24 |
0.59 |
217 |
2039-87-4 |
o-Chlorostyrene |
III |
4218 |
2812 |
50 |
18290 |
2074-50-2 |
Paraquat
dimethyl sulfate, as the cation, inhalable fraction (see Paraquat, as the
cation, inhalable fraction, CAS# 4685-14-7) |
|
|
|
|
|
2104
– 64 – 5 |
EPN,
inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
2179
– 59 – 1 |
Allyl propyl disulfide |
II |
15 |
10 |
0.18 |
66 |
2234
– 13 – 1 |
Octachloronaphthalene |
III |
1.5 |
0.99 |
0.018 |
6.5 |
2238
– 07 – 5 |
Diglycidyl ether (DGE) |
I |
0.19 |
0.13 |
0.0023 |
0.82 |
2425
– 06 – 1 |
Captafol, inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
2426
– 08 – 6 |
n-Butyl glycidyl ether (BGE) |
I |
57 |
38 |
0.68 |
247 |
2451
– 62 – 9 |
1,3,5-Triglycidyl-s-triazinetrione |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
2528
– 36 – 1 |
Dibutyl phenyl phosphate |
II |
18 |
12 |
0.21 |
78 |
2698
– 41 – 1 |
o-Chlorobenzylidene malononitrile, inhalable fraction and
vapor |
I |
1.6 |
0.93 |
0.019 |
6.9 |
2699
– 79 – 8 |
Sulfuryl
fluoride |
I |
75 |
50 |
0.89 |
325 |
2764
– 72 – 9 |
Diquat,
as the cation, inhalable fraction |
I |
1.8 |
1.2 |
0.021 |
7.8 |
2764
– 72 – 9 |
Diquat,
as the cation, respirable fraction |
I |
0.36 |
0.24 |
0.0042 |
1.5 |
2921
– 88 – 2 |
Chlorpyrifos,
inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
2871-90-6 |
Clopidol,
inhalable fraction and vapor |
II |
21 |
10 |
0.25 |
92 |
3033
– 62 – 3 |
bis(2-dimethylaminoethyl)
ether (DMAEE) |
I |
1.6 |
0.78 |
0.019 |
6.9 |
3333
– 52 – 6 |
Tetramethyl
succinonitrile, inhalable fraction and vapor |
I |
10 |
6.7 |
0.12 |
43 |
3383
– 96 – 8 |
Temephos,
inhalable fraction |
II |
5.0 |
3.4 |
0.059 |
22 |
3425-89-6 |
4-Methyl-1,2,3,6-
tetrahydrophthalic anhydride (see Methyltetrahydrophthalic anhydride isomers, CAS# 0-00-0) |
|
|
|
|
|
3547-04-4
|
DDE (1,1-Dichloro-2,2-bis(P-Chlorophenyl)) |
I |
0.10 |
0.10 |
0.0012 |
0.43 |
3689
– 24 – 5 |
Sulfotep
(TEDP), inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
3710-84-7 |
N,N-
Diethylhydroxylamine |
I |
36 |
17 |
0.43 |
156 |
3825
– 26 – 1 |
Ammonium
perfluorooctanoate |
I |
0.050 |
0.024 |
0.00059 |
0.22 |
4016
– 14 – 2 |
Isopropyl
glycidyl ether (IGE) |
II |
1197 |
798 |
14 |
5191 |
4098
– 71 – 9 |
Isophorone
diisocyanate |
I |
0.16 |
0.11 |
0.0019 |
0.69 |
4170
– 30 – 3 |
Crotonaldehyde |
I |
3.1 |
2.0 |
0.037 |
13 |
4685-14-7 |
Paraquat
as the cation, inhalable fraction |
I |
0.18 |
0.12 |
0.0021 |
0.77 |
5124
– 30 – 1 |
Methylene
bis(4-cyclohexylisocyanate) |
III |
0.80 |
0.54 |
0.0095 |
3.5 |
5333-84-6 |
1,2,3,6-Tetrahydro-3-methylphthalic
anhydride (see Methyltetrahydrophthalic anhydride
isomers, CAS# 0-00-0) |
|
|
|
|
|
5392
– 40
– 5 |
Citral, inhalable
fraction and vapor |
I |
89 |
60 |
1.1 |
386 |
5714
– 22 – 7 |
Sulfur
pentafluoride |
I |
0.40 |
0.24 |
0.0048 |
1.7 |
6018-89-9 |
Nickel
acetate, as Ni, inhalable fraction (see Nickel, soluble inorganic compounds,
as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
6153-56-6 |
Oxalic
acid, dihydrate |
I |
3.6 |
2.4 |
0.042 |
15 |
6385
– 62 – 2 |
Diquat
dibromide monohydrate, as the cation, inhalable fraction (see Diquat,
as the cation, inhalable fraction, CAS# 2764-72-9) |
|
|
|
|
|
6385-62-2 |
Diquat
dibromide monohydrate, as the cation, respirable fraction (see Diquat,
as the cation, respirable fraction, CAS# 2764-72-9) |
|
|
|
|
|
6423
– 43 – 4 |
Propylene glycol dinitrate |
II |
1.7 |
1.1 |
0.020 |
7.4 |
6923
– 22 – 4 |
Monocrotophos, inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
7085-85-0 |
Ethyl 2-cyanoacrylate |
II |
5.2 |
3.4 |
0.061 |
22 |
7429
– 90 – 5 |
Aluminum metal and insoluble compounds – respirable fraction |
II |
5.0 |
3.4 |
0.059 |
22 |
7439
– 92 – 1 |
Lead,
and inorganic compounds as Pb |
I |
0.15 |
0.12 |
0.0018 |
0.65 |
7439
– 96 – 5 |
Manganese,
elemental and inorganic compounds, as Mn, respirable fraction |
II |
0.10 |
0.050 |
0.0012 |
0.44 |
7439
– 96 – 5 |
Manganese,
elemental and inorganic compounds, as Mn, inhalable fraction |
II |
0.50 |
0.050 |
0.0060 |
0.81 |
7439
– 97 – 6 |
Mercury,
aryl compounds |
I |
0.36 |
0.30 |
0.0043 |
1.6 |
7439
– 97 – 6 |
Mercury,
alkyl compounds |
I |
0.30 |
0.30
|
0.0036 |
1.3 |
7439
– 97 – 6 |
Mercury,
elemental and inorganic forms |
I |
0.30 |
0.30 |
0.0036 |
1.3 |
7439
– 98 – 7 |
Molybdenum
metal and insoluble compounds, as Mo; inhalable fraction |
I |
36 |
24 |
0.43 |
156 |
7439
– 98 – 7 |
Molybdenum
metal and insoluble compounds, as Mo, respirable fraction |
I |
11 |
7.1 |
0.13 |
48 |
7439
– 98 – 7 |
Molybdenum
soluble compounds, as Mo, respirable fraction |
I |
1.8 |
1.2 |
0.021 |
7.8 |
7440
– 02 – 0 |
Nickel,
insoluble, inorganic compounds, as Ni, inhalable fraction |
I |
0.71 |
0.48 |
0.0085 |
3.1 |
7440
– 02 – 0 |
Nickel,
elemental, as Ni, inhalable fraction |
I |
5.4 |
3.6 |
0.064 |
23 |
7440
– 02 – 0 |
Nickel,
soluble inorganic compounds, as Ni, inhalable fraction |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
7440-06-4 |
Platinum
metal |
II |
5.0 |
3.4 |
0.060 |
22 |
7440
– 06 – 4 |
Platinum,
soluble salts, as Pt |
II |
0.010 |
0.0070 |
0.00012 |
0.043 |
7440
– 16 – 6 |
Rhodium,
soluble compounds |
II |
0.050 |
0.034 |
0.00059 |
0.22 |
7440
– 22 – 4 |
Silver
metal, dust and fume |
II |
0.50 |
0.34 |
0.0059 |
2.2 |
7440
– 22 – 4 |
Silver and compounds as Ag, soluble compounds |
II |
0.050 |
0.034 |
0.00059 |
0.22 |
7440
– 28 – 0 |
Thallium
and
compounds, as Tl, inhalable fraction |
I |
0.071 |
0.048 |
0.00084 |
0.31 |
7440
– 31 – 5 |
Tin, metal, inhalable fraction |
II |
10 |
6.7 |
0.12 |
43 |
7440
– 31 – 5 |
Tin, organic compounds, as Sn |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
7440
– 31 – 5 |
Tin and inorganic compounds (not- SnH4 and indium tin oxide), as Sn, inhalable
fraction |
II |
10 |
6.7 |
0.12 |
43 |
7440
– 33 – 7 |
Tungsten
and compounds in the absence of cobalt, as W, respirable fraction |
I |
11 |
7.1 |
0.13 |
46 |
7440
– 36 – 0 |
Antimony
and compounds, as Sb |
I |
1.8 |
1.2 |
0.21 |
7.8 |
7440
– 38 – 2 |
Arsenic
and inorganic compounds, as As |
I |
0.036 |
0.024 |
0.00043 |
0.16 |
7440
– 39 – 3 |
Barium
and soluble compounds, as Ba |
II |
2.5 |
1.7 |
0.030 |
11 |
7440
– 41 – 7 |
Beryllium
and compounds, as Be, inhalable fraction |
I |
0.00018 |
0.00012 |
0.0000021 |
0.00077 |
7440
– 43 – 9 |
Cadmium
and compounds, as Cd, respirable fraction |
I |
0.0071 |
0.0048 |
0.000085 |
0.031 |
7440-43-9 |
Cadmium
and compounds, as Cd, total particulate |
I |
0.036 |
0.024 |
0.00042 |
0.16 |
7440-48-4 |
Cobalt
and inorganic compounds, as Co, inhalable fraction |
II |
0.14 |
0.067 |
0.0 017 |
0.61 |
7440
– 48 – 4 |
Hard
metal containing Cobalt and Tungsten carbide, as Co, thoracic particulate
matter |
I |
0.018 |
0.012 |
0.00021 |
0.077 |
7440
– 50 – 8 |
Copper,
dusts and mists, as Cu |
I |
3.6 |
2.4 |
0.043 |
16 |
7440
– 50 – 8 |
Copper,
fume |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
7440
– 58 – 6 |
Hafnium
and compounds, as Hf |
III |
7.4 |
5.0 |
0.088 |
32 |
7440
– 61 – 1 |
Uranium
(natural) soluble and insoluble, as U |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
7440
– 65 – 5 |
Yttrium
and compounds, as Y |
III |
15 |
9.9 |
0.18 |
65 |
7440 –
74 – 6 |
Indium and
compounds, as In |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
7553
– 56 – 2 |
Iodine, inhalable fraction and vapor |
II |
0.52 |
0.35 |
0.0062 |
2.3 |
7572
– 29 – 4 |
Dichloroacetylene |
I |
1.4 |
0.93 |
0.017 |
6.1 |
7580
– 67 – 8 |
Lithium hydride, inhalable fraction |
III |
0.83 |
0.50 |
0.0099 |
3.6 |
7616
– 94 – 6 |
Perchloryl fluoride |
II |
65 |
44 |
0.77 |
282 |
7631
– 90 – 5 |
Sodium
bisulfite |
II |
25 |
17 |
0.30 |
108 |
7637
– 07 – 2 |
Boron
trifluoride |
I |
1.0 |
0.68 |
0.012 |
4.4 |
7646-79-9 |
Cobalt
chloride, as Co, inhalable fraction (see Cobalt and inorganic compounds, as
Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
7646
– 85 – 7 |
Zinc
chloride fume |
I |
3.6 |
2.4 |
0.043 |
16 |
7647
– 01 – 0 |
Hydrogen
chloride |
I |
20 |
20 |
0.24 |
87 |
7664
– 39 – 3 |
Hydrogen
fluoride, as F |
I |
1.5 |
0.98 |
0.018 |
6.5 |
7664
– 41 – 7 |
Ammonia |
II |
500 |
500 |
5.9 |
2168 |
7664
– 93 – 9 |
Sulfuric
acid, thoracic particulate matter |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
7681-11-0 |
Potassium
iodide, inhalable fraction and vapor |
II |
0.34 |
0.23 |
0.0041 |
1.5 |
7681
– 49 – 4 |
Sodium
fluoride, as F, (see Flourides, as F, CAS# 0-00-0) |
|
|
|
|
|
7681
– 57 – 4 |
Sodium
metabisulfite |
II |
35 |
17 |
0.42 |
152 |
7681-82-5 |
Sodium
iodide, inhalable fraction and vapor |
II |
0.31 |
0.21 |
0.0037 |
1.3 |
7697
– 37 – 2 |
Nitric
acid |
I |
19 |
12 |
0.23 |
82 |
7705
– 08 – 0 |
Ferric
chloride (as iron, soluble salt) |
II |
5.0 |
3.4 |
0.059 |
22 |
7718-54-9 |
Nickel
chloride, as Ni, inhalable fraction (see Nickel, soluble inorganic compounds,
as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
7719
– 09 – 7 |
Thionyl
chloride |
I |
3.5 |
2.3 |
0.041 |
15 |
7719
– 12 – 2 |
Phosphorus
trichloride |
I |
3.9 |
2.6 |
0.046 |
17 |
7720-78-7 |
Ferrous
sulfate (Iron salts, soluble, as Fe) |
I |
5.0 |
2.4 |
0.059 |
22 |
7722
– 84 – 1 |
Hydrogen
peroxide |
II |
9.9 |
4.7 |
0.12 |
43 |
7726
– 95 – 6 |
Bromine |
II |
3.3
|
2.2 |
0.039 |
14 |
7727-43-7 |
Barium sulfate, inhalable fraction |
II |
104 |
50 |
1.2 |
452 |
7738-94-5 |
Chromic acid, as Cr(VI) inhalable fraction (see Hexavalent
chromium compounds, as Cr(VI), inhalable fraction, CAS# 18540-29-9) |
|
|
|
|
|
7758
– 94 – 3 |
Ferrous chloride (as iron, soluble salt) |
II |
5.0 |
3.4 |
0.059 |
22 |
7758 – 97 –
6 |
Lead chromate,
as Cr(VI), inhalable fraction (see Hexavalent chromium, as Cr(VI), inhalable
fraction, CAS# 18540-29-9) |
|
|
|
|
|
7773-01-5 |
Manganese (II)
chloride, as Mn, respirable fraction (see Manganese elemental and inorganic
compounds, as Mn, respirable fraction, CAS# 7439-96-5) |
|
|
|
|
|
7773-01-5 |
Manganese (II)
chloride, as Mn, inhalable fraction
(see Manganese elemental and inorganic compounds, as Mn, inhalable
fraction, CAS# 7439-96-5) |
|
|
|
|
|
7775-11-3 |
Sodium chromate,
as Cr(VI), inhalable fraction (see Hexavalent chromium compounds, as Cr(VI),
inhalable fraction, CAS# 18540-29-9) |
|
|
|
|
|
7778-50-9 |
Potassium
dichromate, as Cr(VI) inhalable fraction (see Hexavalent chromium compounds,
as Cr(VI), inhalable fraction, CAS# 18540-29-9) |
|
|
|
|
|
7782
– 41 – 4 |
Fluorine,
as F |
I |
0.56 |
0.37 |
0.0066 |
2.4 |
7782 –
42 –
5 |
Graphite (all
forms except graphite fibers), respirable fraction |
II |
28 |
6.7 |
0.33 |
109 |
7782 –
49 –
2 |
Selenium and
compounds, as Se |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
7782
– 50 – 5 |
Chlorine |
I |
1.0 |
0.69 |
0.012 |
4.5 |
7782
– 65 – 2 |
Germanium
tetrahydride |
II |
4.4 |
2.1 |
0.052 |
19 |
7783
– 06 – 4 |
Hydrogen
sulfide |
I |
50
|
2.0 |
0.59
|
33 |
7783
– 07 – 5 |
Hydrogen
selenide, as Se |
I |
0.57 |
0.38 |
0.0068 |
2.5 |
7783
– 41 – 7 |
Oxygen
difluoride |
I |
0.39 |
0.26 |
0.0046 |
1.7 |
7783
– 54 – 2 |
Nitrogen
trifluoride |
II |
146 |
97 |
1.7 |
633 |
7783
– 60 – 0 |
Sulfur
tetrafluoride |
I |
1.8 |
1.0 |
0.021 |
7.8 |
7783
– 79 – 1 |
Selenium
hexafluoride, as Se |
I |
0.57 |
0.38 |
0.0068 |
2.5 |
7783 –
80 –
4 |
Tellurium
hexafluoride, as Te |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
7784
– 42 – 1 |
Arsine |
I |
0.057 |
0.050 |
0.00068 |
0.25 |
7786
– 34 – 7 |
Mevinphos, inhalable fraction and vapor |
I |
0.33 |
0.22 |
0.0039 |
1.4 |
7786
– 81 – 4 |
Nickel sulfate, as NI, inhalable fraction (see Nickel soluble
and inorganic compounds, as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
7787-49-7 |
Beryllium fluoride, as Be, inhalable fraction (see Beryllium and
compounds, as Be, inhalable fraction, CAS# 7440-41-7) |
|
|
|
|
|
7789-00-6 |
Potassium chromate, as Cr(VI), inhalable fraction (see
Hexavalent chromium compounds, as Cr(VI), inhalable fraction, CAS#
18540-29-9) |
|
|
|
|
|
7789-02-8 |
Chromium nitrate, nonahydrate, as Cr(III), inhalable fraction
(see Trivalent chromium compounds, as Cr(III), inhalable fraction, CAS#
16065-83-1) |
|
|
|
|
|
7789-04-0 |
Chromium phosphate, as Cr (III), inhalable fraction (see
Trivalent chromium compounds, as Cr (III), inhalable fraction, CAS#
16065-83-1) |
|
|
|
|
|
7789 –
06 –
2 |
Strontium
chromate, as Cr (VI), inhalable fraction (see Hexavalent chromium compounds,
as Cr (VI), inhalable fraction, CAS# 18540-29-9) |
|
|
|
|
|
7789-09-5 |
Ammonium
dichromate, as Cr (VI) inhalable fraction (see Hexavalent chromium compounds,
as Cr (VI), inhalable fraction, CAS# 18540-29-9) |
|
|
|
|
|
7789-12-0 |
Sodium
dichromate, dehydrate, as Cr (VI), inhalable fraction (see Hexavalent
chromium compounds, as Cr(VI), inhalable fraction CAS# 18540-29-9) |
|
|
|
|
|
7789
– 30 – 2 |
Bromine pentafluoride |
III |
11 |
7.1 |
0.13 |
48 |
7790
– 91 – 2 |
Chlorine trifluoride |
I |
1.5 |
0.91 |
0.018 |
6.5 |
7803
– 51 – 2 |
Phosphine |
I |
0.30 |
0.30 |
0.0036 |
1.3 |
7803 –
52 –
3 |
Antimony hydride |
I |
1.8 |
1.2 |
0.021 |
7.8 |
8001
– 35 – 2 |
Chlorinated
camphene |
I |
1.8 |
1.2 |
0.021 |
7.8 |
8002
– 05 – 9 |
Petroleum
Distillate |
I |
10000 |
4762 |
119 |
43365 |
8003
– 34 – 7 |
Pyrethrum |
I |
18 |
12 |
0.21 |
78 |
8006
– 64 – 2 |
Turpentine
and select monoprenes |
II |
558 |
372 |
6.6 |
2420 |
8008
– 20 – 6 |
Kerosene, as total hydrocarbon vapor |
II |
1006 |
671 |
12 |
4362 |
8012
– 95 – 1 |
Mineral
oil, excluding metal working fluids, pure, highly
and severely refined, inhalable fraction |
II |
25 |
17 |
0.30 |
108 |
8022
– 00 – 2 |
Methyl
demeton, inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
8052
– 41 – 3 |
Stoddard
solvent |
II |
2641 |
1761 |
31 |
11453 |
8052
– 42 – 4 |
Asphalt
(Bitumen) fume, as benzene soluble aerosol, inhalable fraction |
II |
25 |
17 |
0.30 |
108 |
8065
– 48 – 3 |
Demeton,
inhalable fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
9002
– 86 – 2 |
Polyvinyl
chloride (PVC) respirable fraction |
II |
5.0 |
3.4 |
0.059 |
22 |
9006
– 04 – 6 |
Natural rubber latex, as inhalable allergenic proteins |
II |
0.00050 |
0.00034 |
0.0000060 |
0.0022 |
9014
– 01 – 1 |
Subtilisins
as crystalline active enzyme |
II |
0.00030 |
0.00020 |
0.0000036 |
0.0013 |
10024
– 97 – 2 |
Nitrous oxide |
I |
321 |
214 |
3.8 |
1392 |
10025
– 67 – 9 |
Sulfur monochloride |
I |
22 |
13 |
0.26 |
95 |
10025-73-7 |
Chromium chloride, as Cr(III), inhalable fraction (see Trivalent
chromium compounds, as Cr(III), inhalable fraction, CAS# 16065-83-1) |
|
|
|
|
|
10025
– 87 – 3 |
Phosphorus oxychloride |
I |
2.3 |
1.5 |
0.027 |
10 |
10026
– 13 – 8 |
Phosphorus pentachloride |
I |
3.0 |
2.0 |
0.036 |
13 |
10026-22-9 |
Cobaltous nitrate, as Co, inhalable fraction (see Cobalt and
inorganic compounds, as Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
10035
– 10 – 6 |
Hydrogen bromide |
II |
37 |
22 |
0.44 |
160 |
10043
– 35 – 3 |
Boric acid, inhalable fraction (see
Borate compounds, inorganic, inhalable fraction, CAS# 0-00-0) |
|
|
|
|
|
10049
– 04 – 4 |
Chlorine
dioxide |
I |
0.98 |
0.20 |
0.012 |
4.3 |
10060-12-5 |
Chromium
chloride, hexahydrate, as Cr(III), inhalable fraction (see Trivalent chromium
compounds, as Cr(III), inhalable fraction, CAS# 16065-83-1) |
|
|
|
|
|
10101-53-8 |
Chromium
sulfate, as Cr(III), inhalable fraction (see Trivalent chromium compounds, as
Cr(III), inhalable fraction, CAS# 16065-83-1) |
|
|
|
|
|
10101-97-0 |
Nickel
sulfate, as Ni, inhalable fraction (see Nickel, soluble inorganic compounds,
as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
10102
– 43 – 9 |
Nitric
oxide |
II |
156 |
104 |
1.9 |
676 |
10108-64-2 |
Cadmium
chloride, as Cd, respirable fraction (see Cadmium and compounds, as Cd,
respirable fraction, CAS# 7440-43-9) |
|
|
|
|
|
10108-64-2 |
Cadmium
chloride, as Cd, total particulate (see Cadmium and compounds, as Cd, total
particulate, CAS# 7440-43-9) |
|
|
|
|
|
10124-36-4 |
Cadmium
sulfate, as Cd, respirable fraction (see Cadmium and compounds, as Cd, respirable
fraction, CAS# 7440-43-9) |
|
|
|
|
|
10124-36-4 |
Cadmium
sulfate, as Cd, total particulate (see Cadmium and compounds, as Cd, total
particulate, CAS# 7440-43-9) |
|
|
|
|
|
10124-43-3 |
Cobaltous
sulfate, as Co, inhalable fraction (see Cobalt and inorganic compounds, as
Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
10141-05-6 |
Cobalt
nitrate, as Co, inhalable fraction (see Cobalt and inorganic compounds, as
Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
10210 – 68 – 1 |
Cobalt carbonyl,
as Co |
II |
0.50 |
0.34 |
0.0059 |
2.2 |
10294
– 33 – 4 |
Boron
tribromide |
III |
120 |
71 |
1.4 |
518 |
10294-34-5 |
Boron
trichloride |
III |
56 |
33 |
0.66 |
243 |
10294-50-5 |
Cobaltous
phosphate, as Co, inhalable fraction (see Cobalt and inorganic compounds, as
Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
10361-37-2 |
Barium
chloride, as Ba (see Barium and soluble compounds, as Ba, CAS# 7440-39-3) |
|
|
|
|
|
10421-48-4 |
Ferric
nitrate (Iron salts, soluble, as Fe) |
III |
21 |
9.9 |
0.25 |
90 |
10588
– 01 – 9 |
Sodium
dichromate, as Cr(VI), inhalable fraction (see Hexavalent chromium compounds,
as Cr(VI), inhalable fraction, CAS# 18540-29-9) |
|
|
|
|
|
11070-44-3 |
Methyltetrahydrophthalic
anhydride (see Methyltetrahydrophthalic anhydride
isomers, CAS# 0-00-0) |
|
|
|
|
|
11097
– 69 – 1 |
Chlorodiphenyl
(54% chlorine) |
I |
1.8 |
1.2 |
0.021 |
7.8 |
12001 –
26 –
2 |
Mica, respirable
fraction |
II |
15 |
10 |
0.18 |
65 |
12035
– 72 – 2 |
Nickel subsulfide (as Ni), inhalable
fraction |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
12036-22-5 |
Tungsten oxide, as W, respirable fraction (see Tungsten and
compounds, in absence of cobalt, as W, respirable fraction, CAS# 7440-33-7) |
|
|
|
|
|
12054-48-7 |
Nickel hydroxide, as Ni, inhalable fraction (see Nickel,
insoluble inorganic compounds, as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
12070-12-1 |
Hard metal containing cobalt and tungsten carbide, as Co
thoracic particulate matter |
I |
0.018 |
0.012 |
0.00021 |
0.077 |
12079 –
65 –
1 |
Manganese
cyclopentadienyl tricarbonyl, as Mn |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
12108 –
13 –
3 |
2-Methylcyclopentadienyl
manganese tricarbonyl, as Mn |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
12138-09-9 |
Tungsten
disulfide, as W, respirable fraction (see Tungsten and compounds, in absence
of cobalt, as W, respirable fraction, CAS# 7440-33-7) |
|
|
|
|
|
12185
– 10 – 3 |
Phosphorus (yellow) |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
12314-42-0 |
Sodium chromite, as Cr(III), inhalable fraction (see Trivalent
chromium compounds, as Cr(III), inhalable fraction, CAS# 16065-83-1) |
|
|
|
|
|
12336-95-7 |
Chromium hydroxide sulfate, as Cr(III), inhalable fraction (see
Trivalent chromium compounds, as Cr(III), inhalable fraction, CAS#
16065-83-1) |
|
|
|
|
|
12607-70-4 |
Nickel carbonate hydroxide, as Ni, inhalable fraction (see
Nickel, insoluble inorganic compounds, as Ni, inhalable fraction, CAS#
7440-02-0) |
|
|
|
|
|
12656 –
85 –
8 |
Molybdate Orange
as Mo, respirable fraction (see
Molybdenum, as Mo, soluble compounds, respirable fraction, CAS# 7439-98-7) |
|
|
|
|
|
13071
– 79 – 9 |
Terbufos,
inhalable fraction and vapor |
I |
0.036 |
0.024 |
0.00043 |
0.16 |
13121
– 70 – 5 |
Cyhexatin |
I |
18 |
12 |
0.21 |
78 |
13149 –
00 –
3 |
Hexahydrophthalic anhydride, cis-
isomers, inhalable fraction and vapor (see Hexahydrophthalic anhydride, all isomers, inhalable
fraction and vapor, CAS# 85-42-7) |
|
|
|
|
|
13327-32-7 |
Beryllium
hydroxide, as Be, inhalable fraction (see Beryllium and compounds, as Be, inhalable
fraction, CAS# 7440-41-7) |
|
|
|
|
|
13463
– 39 – 3 |
Nickel
carbonyl, as Ni |
I |
1.2 |
0.83 |
0.015 |
5.4 |
13463
– 40 – 6 |
Iron
pentacarbonyl, as Fe |
I |
1.2 |
0.55 |
0.014 |
5.2 |
13463
– 67 – 7 |
Titanium
dioxide |
II |
50 |
34 |
0.59 |
217 |
13466 – 78 – 9 |
3-Carene
(see Turpentine and select monoterpenes, CAS# 8006-64-2) |
|
|
|
|
|
13478-60-7 |
Nickel
nitrate, as Ni, inhalable fraction (see Nickel, soluble inorganic compounds,
as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
13494
– 80
– 9 |
Tellurium, and
compounds, as Te, excluding hydrogen telluride |
I |
0.36 |
0.24 |
0.0043 |
1.6 |
13530 – 65 – 9 |
Zinc
chromate, as Cr(VI),
inhalable fraction (see Hexavalent chromium compounds, as Cr(VI), inhalable
fraction, CAS# 18540-29-9) |
|
|
|
|
|
13765 – 19 –
0 |
Calcium
chromate, as Cr(VI), inhalable fraction (see Hexavalent chromium compounds,
as Cr(VI), inhalable fraction, CAS# 18540-29-9) |
|
|
|
|
|
13770 – 89 – 3 |
Nickel
sulfamate as Ni, inhalable fraction (see Nickel, soluble and inorganic compounds,
as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
13838 – 16 – 9 |
Enflurane |
I |
2021 |
1348 |
24 |
8764 |
13983-17-0 |
Calcium silicate, naturally occurring as Wollastonite Inhalable
fraction containing no asbestos and <1% crystalline silica |
II |
5.0 |
3.4 |
0.060 |
22 |
14166 – 21 – 3 |
Hexahydrophthalic
anhydride, trans-isomer, inhalable fraction and
vapor (see Hexahydrophthalic anhydride, all
isomers, inhalable fraction and vapor, CAS# 85-42-7) |
|
|
|
|
|
14464 – 46 – 1 |
Silica, Crystalline-Cristobalite
– respirable fraction |
I |
0.089 |
0.060 |
0.0011 |
0.39 |
14484 – 64 – 1 |
Ferbam,
inhalable fraction |
I |
18 |
12 |
0.21 |
78 |
14639-25-9 |
Chromium
picolinate, as Cr(III), inhalable fraction (see Trivalent chromium compounds,
as Cr(III), inhalable fraction, CAS# 16065-83-1) |
|
|
|
|
|
14807 – 96 – 6 |
Talc
containing asbestos fibers, respirable fraction |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
14807 –
96 –
6 |
Talc containing
no asbestos fibers, respirable fraction |
II |
10 |
6.7 |
0.12 |
43 |
14808 – 60 – 7 |
Silica, Crystalline-α-quartz
– respirable fraction |
I |
0.089 |
0.060 |
0.0011 |
0.39 |
14857 – 34 – 2 |
Dimethylethoxysilane |
II |
11 |
7.0 |
0.13 |
48 |
14977 – 61 – 8 |
Chromyl chloride, as Cr(VI), inhalable fraction and vapor |
I |
0.0023 |
0.10 |
0.000027 |
0.0098 |
15244-36-7 |
Manganese (II) sulfate, as Mn, respirable fraction (see
Manganese elemental and inorganic compounds, as Mn, respirable fraction, CAS#
7439-96-5) |
|
|
|
|
|
15244-36-7 |
Manganese (II) sulfate, as Mn, inhalable fraction (see Manganese
elemental and inorganic compounds, as Mn, inhalable fraction, CAS# 7439-96-5) |
|
|
|
|
|
15972 – 60 – 8 |
Alachlor, inhalable fraction and vapor |
I |
3.6 |
2.4 |
0.042 |
15 |
16065-83-1 |
Trivalent chromium compounds, as Cr(III), inhalable fraction |
II
|
0.015 |
0.010 |
0.00018 |
0.065 |
16122-03-5 |
Nickel ammonium chloride, as Ni, inhalable fraction (see Nickel,
soluble inorganic compounds, as Ni, inhalable fraction, CAS# 7440-02-0) |
|
|
|
|
|
16219 – 75 –
3 |
Ethylidene norbornene |
I |
35 |
23 |
0.42 |
152 |
16752 – 77 – 5 |
Methomyl,
inhalable fraction and vapor |
I |
0.71 |
0.48 |
0.0085 |
3.1 |
16842 –
03 –
8 |
Cobalt hydrocarbonyl, as Co |
II |
0.70 |
0.34 |
0.0084 |
3.1 |
17194-00-2 |
Barium
hydroxide, as Ba (see Barium and soluble compounds, as Ba, CAS# 7440-39-3) |
|
|
|
|
|
17702 – 41 – 9 |
Decaborane |
I |
0.89 |
0.60 |
0.011 |
3.9 |
17804 – 35 – 2 |
Benomyl,
inhalable fraction |
I |
3.6 |
2.4 |
0.043 |
16 |
18282-10-5 |
Tin
(VI) oxide, as Sn, inhalable fraction (see Tin, and inorganic compounds, not
SnH4
or indium tin oxide, as Sn, inhalable fraction, CAS#
7440-31-5) |
|
|
|
|
|
18540-29-9 |
Hexavalent
chromium compounds, as Cr(VI), inhalable fraction |
I |
0.00071 |
0.00048 |
0.0000085 |
0.0031 |
19287 –
45 – 7 |
Diborane |
I |
0.39 |
0.26 |
0.0046 |
1.7 |
19438-63-2 |
6-Methyl-3,4,5,6-tetrahydro-2-benzofuran-1,3-dione
(see Methyltetrahydrophthalic anhydride isomers,
CAS# 0-00-0) |
|
|
|
|
|
19438-64-3 |
5-Methyl-7,7-dihydroisobenzofuran-1,3-(3ah,6h)-dione (see Methyltetrahydrophthalic
anhydride isomers, CAS# 0-00-0) |
|
|
|
|
|
19624 – 22 – 7 |
Pentaborane |
I |
0.046 |
0.031 |
0.00055 |
0.20 |
20816 –
12 –
0 |
Osmium
tetroxide, as Os |
II |
0.011 |
0.0054 |
0.00013 |
0.048 |
21087 – 64 –9 |
Metribuzin |
I |
18 |
12 |
0.21 |
78 |
21651-19-4 |
Tin
(III) oxide, as Sn, inhalable fraction (see Tin, and inorganic compounds, not
SnH4 or
indium tin oxide, as Sn, inhalable fraction, CAS# 7440-31-5) |
|
|
|
|
|
21725-46-2 |
Cyanazine,
inhalable fraction |
II |
0.70 |
0.34 |
0.0084 |
3.1 |
22224 – 92 – 6 |
Fenamiphos – inhalable
fraction and vapor |
I |
0.18 |
0.12 |
0.0021 |
0.78 |
22781-23-3 |
Bendiocarb,
inhalable fraction and vapor |
I |
0.36 |
0.24 |
0.0042 |
1.6 |
25013 – 15 – 4 |
Vinyl
toluene |
II |
1217 |
812 |
14 |
5277 |
25013-82-5 |
Chromium
acetate, as Cr(III), inhalable fraction (see Trivalent chromium compounds, as
Cr(III), inhalable fraction, CAS# 16065-83-1) |
|
|
|
|
|
25154 –
54 –
5 |
Dinitrobenzene,
mixed isomers, inhalable fraction and vapor |
II |
5.0 |
3.4 |
0.060 |
22 |
25167-67-3 |
Butene, all
isomers |
II |
2886 |
1924 |
34 |
12515 |
25321 – 14 – 6 |
Dinitrotoluene,
mixed isomers |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
25322 – 68 – 3 |
Polyethylene
glycol, (average molecular weight 200-600) |
I |
50 |
24 |
0.59 |
217 |
25551 – 13 – 7 |
Trimethyl
benzene (mixed isomers) |
II |
619 |
412 |
7.4 |
2684 |
26140 – 60 – 3 |
Terphenyls
(o-, m- & p- isomers) |
II |
25 |
17 |
0.30 |
108 |
26471 – 62 – 5 |
2,4-
and 2,6-Toluene diisocyanate (as a
mixture), inhalable fraction and vapor |
I |
0.025 |
0.070 |
0.00030 |
0.11 |
26590-20-5 |
Methyltetrahydrophthalic
anhydride (see Methyltetrahydrophthalic anhydride
isomers, CAS# 0-00-0) |
|
|
|
|
|
26628 – 22 –
8 |
Sodium
azide |
I |
1.0 |
0.69 |
0.012 |
4.3 |
26628 – 22 – 8 |
Sodium
azide, as Hydrazoic acid vapor |
I |
0.39 |
0.26 |
0.0046 |
1.7 |
26952 – 21 – 6 |
Isooctyl
alcohol |
III |
5542 |
2639 |
66 |
24033 |
31242 – 93 – 0 |
o-Chlorinated
diphenyl oxide |
III |
7.4 |
5.0 |
0.088 |
32 |
34590 – 94 – 8 |
2
(2-Methoxymethylethoxy) propanol |
II |
3048 |
2032 |
36 |
13218 |
35400 –
43 –
2 |
Sulprofos, inhalable
fraction and vapor |
I |
0.36 |
0.24 |
0.0042 |
1.5 |
42498-58-8 |
2,3,5,6-Tetrahydro-2-methylphthalic
anhydride (see Methylterthydrophthalic anhydride
isomers, CAS# 0-00-0) |
|
|
|
|
|
50926-11-9 |
Indium
tin oxide, respirable fraction |
II |
0.00050 |
0.00034 |
0.0000060 |
0.0022 |
51349-94-1 |
Manganese
(II) phosphate, an Mn, respirable fraction (see Manganese elemental and
inorganic compounds, as Mn, respirable fraction, CAS# 7439-96-5) |
|
|
|
|
|
51349-94-1 |
Manganese
(II) phosphate, as Mn, inhalable fraction (see Manganese elemental and
inorganic compounds, as Mn, inhalable fraction, CAS# 7439-96-5) |
|
|
|
|
|
53469 – 21 – 9 |
Chlorodiphenyl
(42% chlorine) |
I |
3.6 |
2.4 |
0.043 |
16 |
55566 – 30 – 8 |
Tetrakis
(hydroxymethyl) phosphonium sulfate |
I |
7.1 |
4.8 |
0.084 |
31 |
57454-67-8 |
Cobalt
carbonate, as Co, inhalable fraction (see Cobalt and inorganic compounds as
Co, inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
60459-08-7 |
Cobalt sulfate,
as Co, inhalable fraction (see Cobalt and inorganic compounds, as Co,
inhalable fraction, CAS# 7440-48-4) |
|
|
|
|
|
61788
– 32 – 7 |
Hydrogenated
terphenyls (nonirradiated) |
III |
73 |
49 |
0.87 |
317 |
64742 – 81 – 0 |
Kerosene,
as total hydrocarbon vapor |
II |
1006 |
671 |
12 |
4362 |
65996 –
93 –
2 |
Coal tar pitch
volatiles, as benzene soluble aerosol |
I |
0.71 |
0.48 |
0.0084 |
3.1 |
74222 – 97 – 2 |
Sulfometuron
methyl, inhalable fraction and vapor |
II |
25 |
17 |
0.30 |
108 |
86290 – 81 – 5 |
Gasoline |
II |
4477 |
2985 |
53 |
19414 |
95465-99-9 |
Cadusafos,
inhalable fraction and vapor |
I |
0.0036 |
0.0024 |
0.000042 |
0.016 |
111988-49-9 |
Thiacloprid,
inhalable fraction |
I |
0.71 |
0.48 |
0.0085 |
3.1 |
128639-02-1 |
Carfentrazone-ethyl,
inhalable fraction |
II |
5.0 |
3.4 |
0.060 |
22 |
131341-86-1 |
Fludioxonil,
inhalable fraction |
I |
3.6 |
2.4 |
0.042 |
16 |
946578-00-3 |
Sulfoxaflor,
inhalable fraction |
I |
0.36 |
0.24 |
0.0042 |
1.6 |
Footnotes:
a.
A Toxicity Classification as classified in
Env-A 1407, in general:
Toxicity Class I: Classification established pursuant to
Env-A 1407.02.
Toxicity Class II: Classification established pursuant to Env-A
1407.03.
Toxicity Class
III: Classification established pursuant
to Env-A 1407.04.
B Ambient air limit.
C De
minimis values were calculated using non-rounded AALs. The AALs
and de minimis
values represented in this table are rounded to whole numbers or 2 significant figures if less than 10.
E Denotes regulated toxic air pollutants which
have data limitations preventing derivation of AALs in accordance with Env-A 1411.
Source. #6739-B, eff 5-8-98; amd
by #7345, eff 9-22-00; amd by #7616, eff 12-28-01; amd by #7859, eff 4-11-03; amd by
#8095, eff 6-11-04; ss by #8278, eff 2-4-05; amd by #8632, eff 5-26-06; amd by
#9021, eff 11-9-07; ss by #9601, eff 11-25-09; ss by #9865, eff 2-18-11; amd by #10133, eff 6-1-12; amd by
#10550, eff 4-4-14; amd by #12063, eff 12-30-16; ss
by #13334, eff 2-3-22
Appendix A: State Statutes Implemented
Rule |
State Statute Implemented |
Env-A 1401 |
RSA 125-I:1; RSA 125-I:2; RSA
125-I:3, I & II |
Env-A
1402.01(a) & (b) |
RSA
125-I:3, III(a) |
Env-A
1402.01(c) & (d) |
RSA
125-I:3, III(b) |
Env-A
1402.02 |
RSA
125-I:3, III(c) |
Env-A
1402.03 |
RSA
125-I:3, III(c) |
Env-A
1403.01 & 1403.02 |
RSA
125-I:3, I; RSA 125-I:5, I & V |
Env-A
1404 |
RSA
125-I:5, V |
Env-A
1404.07 |
RSA
125-I:5,V & RSA 125-I:2, VI |
Env-A
1405.01 |
RSA
125-I:3, I; RSA 125-I:5, I & V |
Env-A
1405.02-1405.04 |
RSA
125-I:1; RSA 125-I:2; RSA 125-I:3, I & II |
Env-A
1406 |
RSA
125-I:5, I & IV |
Env-A
1407 |
RSA
125-I:2, XIV; RSA 125-I:4 |
Env-A
1408 - 1411 |
RSA
125-I:4 |
Env-A
1412 |
RSA
125-I:4, V |
Env-A
1413 |
RSA
125-I:1; RSA 125-I:5 |
Env-A
1414-1449 |
Reserved |
Env-A
1450 |
RSA
125-I:4 |
Appendix B: Statutory Definitions
RSA 125-C:2
III-a.
"Biomass'' means organic matter used as a fuel, not including wood derived
from construction and demolition debris, as defined in RSA 149-M:4, IV-a; wood
which has been chemically treated; or agricultural crops or aquatic plants or
byproducts from such crops or plants, which have been used to rehabilitate a
contaminated or brownfields site through a process known as
"phytoremediation.''
RSA 125-I:2
VI.
"Compliance boundary'' means the boundary of the property on which the
stationary source is located or an alternate
compliance boundary determined by the department in accordance with rules
adopted pursuant to this chapter.
XVII.
“Uncontrolled emission” means any emission of a regulated toxic air pollutant
from a device or process at a stationary source that is not subject to treatment
or removal by pollution control equipment prior to being emitted to the ambient
air, or is emitted to the ambient air in amounts which
have not been limited by conditions in an enforceable permit or document.